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ABSTRACT
Alterations in Rat Brain Norepinephrine and Dopamine Levels and
Synthesis Rates in Response to Five Neurotoxic Chemicals:
Acrylamide , 2,5 - Hexanedione ,

Tri -~-t olyl

Phosphate ,

Leptophos, and Methyl Mercuric Chloride
by
Charles N. Aldous, Doctor of Philosophy
Utah State University , 1981
Major Professor: Dr. R. P. Sharma
Department: Inte rdepartmental Toxicology Progr am
Acrylamide, 2,5 - hexanedione,

tri-~-tolyl

phosphate and leptophos

belong to three fundamentally different chem i cal classes but al l four
chemicals cause central-peripheral distal axonopathy .
c~npounds

Some of these

have been shown to alter brain steady state levels of

neurotransmit ters or to inhibit the activities of adenosine
triphosphatases which are involved in the uptake and storage of biogenic
amines.

Tests were performed to determine alterations in steady state

levels of rat brain norepinephrine and dopamine in response to doses of
the above chemicals and of the central nervous system toxin, methyl
mercu ric chlo r ide sufficient to cause ataxia .
rate constant estimations were performed.

Cat echolami ne synthesis

Specific activities of

tyrosine in brains of control and treatment groups following intravenous
injection of label led tyrosine were compared to determine if passage of
tyrosine across the blood - brain barrier were affected by treatments .

ix
Levels of the dopam i ne met abo li t e, dihydr oxyp he nylacetic ac i d vtere
assayed in al 1 cases .

Levels of the nor epinephri ne metabol i t e,

3-met hoxy-4-hy droxym ethylethylenegl ycol sulfate, were assayed in
res ponse to acrylamide administration.

Ani mal •.;eights were recor ded at

the beginning and end of the treatment period.

Rats treated with a

cumul ative dose of 250 mg /k g acrylamide had significantl y l01ver
norepinephrine levels than controls .

2,5 - hexanedione admin i strati on

sig nif icantl y i ncreased the dopamine syn thesis rate cons t ant at a
cumulative dose of 21 0 mg/ kg .

Cumulati ve doses of 700 and 21 00 mg/kg

al so appeared to elevate norepineph rine and dopamine synthesis rate
constants , but values were not statistically significant .

Leptop ho s

caused a slight but significant increase in dopamine levels in rats
administered a cumulative dose of 75 mg/k g.

t~ethyl

mercuric chloride

caused variable effects to norepinephrine synthesis rate and l owered
dopamine synthesis rate constant at cumulative doses of 5 to 50 mg/ kg.
No other alterations were seen in levels of catecholamines or of their
metabolites, nor in synthesis rate constants of the catecholamines in
response to admi ni strat ion of the five neurotoxic compounds .

No

evidence of altered blood - brain transport of tyrosine was observed at
any level of neurotoxins administered.

Rats given the highest

cumulative doses of all neur otoxins except

tri -~- tolyl

significantly less weight than control animals.

phosphate gained

It was concluded that

th e four compou nds which cause delayed distal neurotoxicity do not alter
levels of turnover rates of brain catecholamines in a consistent
manner.
(76 pages)

INTRODUCTION
In t he past several decades an unprecedented number of new
chemicals have been em ployed as solvents, pesticides, s pecial lubricants
fo r high-powered engines, rea ctiv e intermed iates in the ma nuf acture of
polymers, and starting materials for many other applications .
Historically , ne•.v chemicals were oft en assumed safe unless proven toxic .
Ina deq uate attention to possibl e sources of contamination, poo r
epidemiological studies, carelessness and poor hygiene in the wo r kplace
or in the preparation of food and beverages fo r human consumpt ion have
all take n their toll in human health.

One largely occupational disease

whic h was not generally recognized until the last 50 yea rs is a delayed
neuropathy , which is characteristically slov1 in onset .
include a variety of chemicall y unrelated s pec ies.

Causative agents

Unf ortunatel y ,

remission of symptoms is ofte n slow and incomplete after the cessation
of exposure.

The disease was once called a "dying back synd r ome" or

"demyelination disease" because of a peculiar prog ressi on of numbness,
paresthesia s, and mo tor disability from the distal extremities of the
body towa rd mo r e proximal regions.

Concu rrent with sensory and motor

function deficits, histological features such as demyelinated,
degenerating axons were found in tissues involved.
In recent years it has been determined that demyelination was
secondary to axonal degeneration, and the term "central-peripheral
distal axonopathy" has been coined to better describe the disease 1vhich
entails degeneration primar i ly, but not exclusively , of distal po rtions
of the larger diameter myelinated nerve fibers (Spencer and Sc haumb ur g ,

2

1977) .

There is good evidence that initial insult occu rs directly to

the axon

( Lowndes~

_9_1_., 1974).

Two major theories re ga rdi ng the

critical biochemical lesions of the axonopathy have been proposed .

1~ .

K. Johnson (1975a) is the leading proponent of a theory relating
neu ropathy, caused by certain c 1asses of organopl1osphates, to cava 1ent
bo nding of a neurotoxic organophosphate molecule to a specific
"neurotoxic esterase".

This is followed by subsequent hydrolysis of a

l eaving grou p to leave a charged residue in the site of phospho ryl ati on .
The connection between the addition of an irreversibly-boun d residue to
this esterase and the progress of the neuropathy is unknown, but the
correlation of the biochemical alteration with the neurotoxic potential
of the disease is impressive.
The second major theory linking a biochemical lesion 1vith
axonopathy

•t~as

espoused by Spencer et _9_1_. (1978).

They found marked

inhi bition of several glycolytic enzymes in response t o acrylamide and
to metabolites of

~-he xa ne.

Such inhibition was postulated to result in

a reduced capacity to supply the energy needed for axonal transport
processes.

This energy deficit in the axon and resulti ng loss of

transport capacity would account for the focal accumulations of
organelles observed in early degenerative processes and, as a symptoms
progress, for the destruction of the axon .
The chemicals associated with distal neuropathy typically cause
degeneration of central as well as peripheral fibers (Spencer and
Schaumburg, 1977) .

Comparatively few studies have been performed on

effects of distal neu r opathic chemicals on interacting systems in the
brain .

Some of the studies 1vhich have been performed have f ound

administration of a sing l e neurotoxic chemical such as acrylamide to

3

alt er steady state leve ls of several neur ot ransmit ters
1980) .

(Dixit ~~·,

The physiologic al proc esses gove rni ng the uptake and sto ra ge of

neurotransmitters and their precursors, the bioch emi cal mecha nisms
invol ved in their metabolism, the active and facilitated processes of
membrane tran sport of transmitters and metabol i tes, and the regulative
fun cti on s which maintain constant or controlled functional le vels of
neu rotransmitt ers under varyi ng environmental conditions have been items
of intense research interest for many years.

Sufficiently sensitive

te chn iq ues have been desc r ibed t o assay levels of neurotransmitters and
their metabolites at or below the nanomo le level .

It is now pos sible t o

measure levels of these compounds in small amounts of brain tissue and
to estimate neurotransmitter synthesis ra t es in specific brain parts .
Significant alte ra tions in levels or synthesis rates of these compounds
permit inferences to be made of the nature of the lesion (s) of
admini stered compo unds .

For example , an elevated level of an acidic

metabolite of a brain amine con current with normal neurotransmitter
synthesis rate would suggest an inhibition of the acid metabolite
trans por t system.

Increased turnover of a neurotransmitter could resu lt

from increased stimulation or hyperexcitability of the nerve, from
impairment of active uptake of released neurotransmitter into the nerve
synapse, or from impaired capacity of synaptic vesicles to sequester
neurotransmitters.
oxidation by

~~AO,

The latter two situations expose transmitters to
so that neurons increase production of transmitters as

a compensato ry mechanism.

In general, more information is de rived from

mo nitoring transmitter turnover rates than levels of neurotransmitters
alo ne, because the compensatory responses of neurons to external stimuli
can be observed as cells alter their rate of neurotransmitter production
to maintain physiological levels

(Neff~~·,

1971).

4

The present study invol ves fo ur compounds knovm to preci pitate
cent r al -p e riph eral distal axonopathy, namely acrylamide, lept opho s,
2, 5- HD and TOTP.

These four compo unds represent three fundamentally

diffe rent chemical families, hence any common biol ogical effect of these
fou r compou nds 1vould probably relate to one commo n featu r e shared by al l
fo ur species, namely delayed neurotoxicity .
te st series is MeHg .

One chemical added to th e

Alt hough not related to the other four compou nds

i n st ructu r e or mechanism of toxic ac tivity , MeHg is an important
environmental pol lutant and is cytotoxic to glial and neuronal cel ls of
the cent ral nervous system.
The majo ri ty of studies to date i nvolv in g del ayed ce ntra l peri pheral distal axonopathy concern histopathological lesions of the
pe ripheral nervous system, the spi na l co rd, th e axons which extend f r om
the spinal co rd into the brain, or with effec ts assumed to result from
lesio ns in those a rea s (Abou-Do ni a, 1979;
Spence r and Schaumbu r g, 1977).

Schaumbu r g ~~·,

19 74 ;

Evid ence is now accumulating that

delaye d-neur otox i c compoun ds, most notably acrylamide, ha ve sig ni ficant
effec ts on neurons located entirely within the brain.

Boy es and Coope r

{1981) found a r educt ion in the amp l itudes of evoked potent ia ls in the
somatosenso ry cortex after st imulat ion of the tibi al nerve in rats fed
approximately 250 mg/kg acrylamide.

Investigat ors inferred that damage

to the cort ex or to cortico-thalamic fibers had occurred.

Di xi t et al .

(1980) found decreases in brain levels of NE , DA, and 5-HT after
administration of 450 mg/kg acrylamide to rats .

Even a single dose of

25 mg/kg acrylamide was sufficient to cause increased DA receptor
bo nding activity while decreasing the beha vioral effects of the DA
agonist, apomorphine, so that i nvestigat ors (Ag rawal

~ ~· ,

1981)

con cluded that nigrostriatal f ibers had been da maged by acrylamide.

Comparatively few studies of 2,5-HD effects upon the central
nervous system have been conducted .

Because of the common effects that

2, 5- HD and acrylamide have on glycolytic enzyme inhibition (Sabri et
~ ••

1979b; Sabr i and Spencer, 1980), it is likely that both compounds

would have similar effects on brain neur ons due either to inhibition of
glycolytic enzymes or to interactions with other susceptible enzymes or
cellular pr oteins .

Farr {1981) found dose-related increases of the 5-HT

metabolite, 5-HIAA acid, after administration of 25 to 250 mg / kg
acrylamide or 210 to 2100 mg /k g 2,5-HD.

Because 5-HT levels and

synthesis rate constants were unchanged in all cases , he concluded that
metabolite accumulation occurred due to inhibition of the acid
metabolite transport system.
The biochemical lesion mos t frequentl y associated with
organophosphate delayed distal neu ropathy is inhibition of a "neu rotoxi c
esterase" (Johnso n, 1975a ) .

Because there is little apparent similarity

between the etiology of distal neuropathy caused by organ ophosphates as
opposed to that associated with acrylamide or 2,5-HD, it appears
unlikely that their central nervous system ma nifestati ons would be
similar.

At least one study has, however, found a decrease in rat brain

DA levels in response to mipafox and leptophos, whereas a third
organophosphorus compound, fenitrothion, did not alter DA levels {Freed
et

~ ••

1976) .

All th ree compounds markedly inhibited rat brain

striata 1 acetylcholinesterase, but only the two compounds \vhi ch 1owe red
DA levels elicited delayed ataxia or motor dysfunction.

It is,

therefore, poss i ble that striatal DA level alterations reflect a
resp onse of the brain to organophosphate compounds which is not me rel y a
sequel of acute anti - acetylcholinesterase effects .

The present study was underta ken to extend the current 1evel of
understanding of central nervous system effects of representative
delayed distal neurotoxic compounds:
l eptophos.

acrylamide, 2,5-HD, TOTP, and

Whole brain NE and DA levels and synthesis rate constants

1vere estimated; alterations in accumulation of labeled Tyr following iv
injections of Tyr into the brain were examined, and catecholamine
metabolite levels 1vere assayed in rats administered these four
compounds.

These chemicals 1vere administered in multiple doses at

levels which were sufficient to cause measurable motor disability during
the respective dosing periods.

Doses 10 and 30 percent of the above

levels were given to determine the sensitivity of catecholamine neurons
to agents which cause delayed distal neuropathy.

Alterations in

function of catecholamine neurons at dose levels below the thresholds at
which clinical symptoms are observed would indicate that these responses
1vere primary effects of de 1ayed neurotoxic compounds rather than
sequelae of gene ralized body dysfunction .
It was hypothesized that damage to neurons which transmit either DA
or NE would cause reduction of respective catecholamine steady state
levels in rats administered the highest doses of acrylamide and 2,5-HD.
Simultaneous synthesis rate constant estimates for NE and DA were
performed to determine v1hether altered steady state catecholamine levels
were due to altered synthesis rates of the two monoamines .

Possible

membrane transpo rt decrements were examined in the case of Tyr entry
into the brain and of efflux of acidic metabol i tes of neurotransmitters
from the brain .

Two organophosphates included in this study, TOTP and

leptophos, cause delayed distal neuropathy, but only leptophos is an
acute acetylcholinesterase inhibitor, and it has been shown to alter

steady st ate DA levels in rat bra in

(F r eed~~·,

1976) .

The

possibility that del ayed distal neurotoxic or ganophosphates alte r
catecholam ine levels or the function of associated neurons, pe rhaps
independently of anti - acetylcholinesterase effects was explored by means
of the same assays as those employed for acrylamide and fo r 2,5-HD.
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REV! EW OF LITERATURE

Acryl ami de
Acrylamide is a highly reactive molecule due to the electron
withdrawing effect of the amide group on the electrons of the adjacent
vinyl group,

The resulting capacity of acryla mide to form polymers and

copolyme rs makes it extremely useful as a flocculent, binder, or gel;
its production measures in the tens of mi ll i ons of pounds per year
(Spence r and Schaumburg, 1974a).
Acrylamide has been extensively studied, particularly in the last
decade, with emphasis on its role as a causative agent of delayed distal
neuropathies.

A recent study by Tilson .t!.

~·

{1979) correlated a

number of neurobehavioral and histological effects of oral doses of 5 to
20 mg/kg of acrylamide given three times weekly for 13 weeks .
effects were observed in animals receiving 5 mg/kg/feeding.

No
Dose-

related degrees of nerve fiber degeneration were obse rve d in rats given
10 mg/kg/feeding or more, 20 mg/kg/feed in g causing nerve fiber degenera tion in all subjects .

Decrements in hi nd limb leg strength, but not i n

forelimb strength, were observed.

Schaumburg .t!.

~·

{1974) reported the

ultrastructural process in the dying-back process in cats.

Animals

receiving 10 mg/kg/day developed a weaving gait in 14- 15 days ,
associated with hindlimb incoordination progressing to a virtual
inability to walk .
tremors.

Higher doses were frequently associated with head

Doses as low as 3 mg/kg caused similar features after a latent

period of 10-23 weeks.

Distal nodes of Ranvier of the plantar nerves

were the scene of the earliest morphological changes.

Distal nodal and

9

paranodal axo nal swe l l i ngs were obs erved in iso lated fibers .

These 1"ere

fil l ed with unusually large numbers of neurofilaments , mitochondria, and
memb ran ous dense bodies .

The most prominent i nternoda 1 features 1"ere

accumu la tions of 10 nm neu r ofilame nt s .

Frequently, invaginations of

adjacent Schwann cell cytoplasm into neur onal fibers 1"ere obse r ved .
Apparentl y abnormal axonal cell constituents 1"ere removed by this
pr ocess .

Spencer and Thomas (1974 ) sugges t that such a phagocytic role

is a prominent featu re in various forms of distal neuropathies.
Sabri and Spencer (1980) postulated that inhibition of enzymes of
glycolysis might be a common link in distal neuropathy associated wi th
acryl ami de and severa 1 other neurotoxic chemicals .

They reported a

dramatic reducti on in GAPD H activity and a modest , but significant
reduction in the activity of PFK when 25 mM acrylamide was incubated
with either the crystalline enzymes or homogenates of rat brain or
sciatic nerve.

Incubation of dithiothreitol with the medium conta i ning

commercial enzymes in advance of acrylamide addition prevented
inhibition of either enzyme , but dithiothreitol could not restore
~·

(1980) fou nd

the sulfhydry l-containing, neuron-specific enolase to be

inhibited~

activity after inhibition by acrylamide .

vivo

and~

unaffected.

Howla nd et

vitro by acrylamide, although total eno l ase activity was
Inhibition of fast axoplasmi c transport of [14l]-leucine in

cat sciatic nerve after acrylamide intoxication reported by l<eir

~~·

(1978) may be both a cause for and a result of dim inis hed capacity for
glycolysis.
Considerable attention has been given to the capacity of acrylamide
to bind to thiol groups.

Hashimoto and Aldridge (1970) noted that

acrylamide is intermediate in capacity to react

wi~h

GSH among analogues

10
v1h i ch display little or no neu r otoxic effect .
acrylam ide wi th non - neurotoxic
equal ~

Further compa ris ons of

~- ( hydr oxym ethy l)-acry l a mide ,

which had

vit ro GSH binding ca pac ity, found the two compounds ve ry

similar in their capacity to bi nd protein and non-protein sulfhydryl
gr oups.

Hence th e neurotoxic potential of acrylamide is not a simple

function of its ability to react with sulfhydryl moieties.

Sharma and

Obe rsteiner (1 g77) did find GSH to give substantial protection t o chick
ganglia cultu res against acrylamide toxicity.

Alternatively , depletion

of GSH with diethylmaleate hastens and potentiates at least one effect
of hi gh doses of acrylamide:
brain NE, DA , and 5-HT

reduction of steady state le vel s of r at

(Dixit~

.!l_., 1g80).

Evidence that thiol group s

protect against acrylamide toxicity is no proof that attack on thiol
groups of sensitive lesions is the primary biochemical lesion caused by
acrylamide.
In view of the mounting evidence that inhibition of glycolysis is a
major effect of several neurotoxins, it is interesting to note that
Dairman

~.!l.·

(1g81) found th at inclusion of 2% sodium pyruvate in the

diet re duced acrylamide -ass oc iated hindlimb muscle weakness , lessened
axonal degeneration in sciatic nerves, and reduced the leve ls of enzyme
markers of lysosomal activity as compared to acrylamide rats not
receiving supplementary pyruvate.
In addition to damage to sensory fibers cited above, Schaumburg et
al. (1g74) described abnormalities and subsequent degeneration of
afferent muscl e spindle fibers and, as intoxication progressed, associated motor ne rve terminals displayed abnormalities.

These authors noted

a tendency for larger, myelinated fibers to be preferentially affected.
Post and Mcleod (1977) found degeneration of large unmyel inated as well
as myel i nated sympathetic fiber types in the splanchnic nerve.
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Considering the variety of nerve cell types shown to be affected by
acrylamide, it is not surprising that brain function might also be
di rect ly affected .

Boyes and Cooper (1981) stimulated the tibial nerves

of rats and noted a 2. 5 fold reducti on in the amplitudes of elicited
peaks associated with activity in thalamus.

Significantly greate r

amplitude reduction was noted in cortical peak amplitudes, suggesting
that dam age to cortex or to thalamocortical fibers mi ght have occurred ,
and tha t such damage mi ght be a cont ributing factor in acrylamide
ataxia.
Other evidence of central neurotoxicity by acryl ami de was reported
by

Ag rawal~~ ·

(1981) who found increased striatal binding of the DA

analogue, 3~-s piroperiodol, after acute acrylamide administration to
rats .

Motor act ivity responses to the DA agonist, apomorphine, were

reduced by acrylamide pretreatment in a dose-rel ated manner.

The

investigators speculated that damage to dopamine neu r ons in
nigrostriatal pathways could explain the two observations .

The increase

in DA r ecepto r binding could be exp lained by a postsynaptic response to
a diminished flux of DA form damaged neurons .

Studies in the same

laboratory found striatal acetylcholine receptor binding as

~~ell

as

striatal DA binding after 14 days treatment with 5 mg/kg/day acrylamide
(Bondy et

~.,

1981).

At higher doses, gamma-aminobuty ri c acid, glycine

and 5-HT recept or binding also increased, suggesting mo re generalized
neuronal damage than evident in the acute tests above.

Partial return

to normal behavio ral functions and ligand bondin g capacity occurred
within eight day s of cessation of treatments .
Farr

~ ~·

(1981) reported a dose-rela ted i ncrease in t he 5-HT

metabolite , 5-HI AA , in respons e to 5 to 50 mg/kg/day acrylamide
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adm i ni stration ov er f i ve days.

Because t here was no chan ge in 5- HT

levels or turnover rates, it is probable that the acid transport system
was affected.
One general feature which is li kel y to affect f unctions of all body
systems is substantial weight loss or diminished 1veight gain in
acrylamide toxicity

(Tilson~~ .,

1979; Schotman

~~.,

1977).

The

1atter authors found onl y part of the body weight difference to be due
to lessened fo od intake, because pair-fed controls gained ap preciabl y
more weight than acrylamide-treated rats.
affected by acrylamide .

Protein metabolism is also

In the same study, the rate of uptake of

[4,5 - 3~]-leucine into neural tissues was reduced in a manner related to

the progress of neuropathic symptoms.

Similarly,

Agrawal~~ ·

(1981)

observed a reduction in rat brain membrane proteins in response to
20/mg/kg acrylamide.
Hexacarbon Neurotoxicity
Neurotoxicity due to hexane and several of its hydroxylated and
ketone der iva tives , part i cularly MnBK and 2,5-HD, has been studied
extensively in recent yea rs .

A review by

Spencer~ ~·

( 1980 )

describes a number of situations where exposure to appreciable levels of
hexane and MnBK has been a common occurrence .

These include pr intin g,

shoemaking, fu rn iture-fini shing and related industries.

Frequently the

worst exposures invo lve small shops where ventilation i s poo r and worker
safety practices inadequate.

In addition to inadvertent exposure in the

workplace , purposeful exposure due to "glue-sniffing" ha s led to human
neuropathic disease .
Spence r and Schaumburg (1977) reported peripheral neu r opathy
similar to that reported previously for acrylamide; giant axonal
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s1vell in gs and associated accumula tions of 10 nm neurofi laments 1vere
characteristic findings.

Frequently, clusters of neurotubules, endo-

plasmic reticulum and often degenerate mitochondria were observed .

Some

deta i 1s 1vere diffe rent from acryl ami de neuropathy, in which damage to
Pacinian co rpuscles an d other nerve terminals 1vere among the first
lesions observed (Spe ncer and Schaumburg, 1974b).

Hexacarbon neuro-

path ic lesions 1vere first observed in non - terminal regions of tibial
nerve branches to calf muscles, whereas abnormalities of terminal portions of sensory nerves appeared later and were less pronounced than in
acr·ylamide-treated animals.

Althou gh both acrylamide and hexacarbon

neuropathy involved central nervous system damage, initial acrylamide
damage was gene rally limited to terminal ends of long my elinated neur ons
whereas early hexacarbon-caused lesions such as giant axonal swellings
were found mo re general ly distributed along the spinal and medullary
tracts .
Several functional features of hexacarbon neuropathy are similar to
acrylamide toxicity .

Takeuchi~

2.}_. (1980) found decreased motor nerve

conduction velocity after hexane treatment but not after non - neurotoxic
pentane or heptane treatment.

Fast axonal transport was apparently

impeded , as evidenced by accumulat i on of labelled organelles outside the
usual microtubule channels in swollen axonal regions following injection
of 3.t!_-leucine into l umbar ventral horns (Griffin ~2.}_. , 1977).
gain was lessened by large doses of 2,5- HD
Krasavage

~

(Takeuchi~

\4eight

2.}_., 1980;

2.}_., 1980) .

DiVincenzo

~ il·

(1976) detected 5- hydroxy-2-hexane and 2,5-HD in

the serum of rats admi nistered hexane .
proceeds by w- 1 oxidation .

Metabolism of MnBK generally

Hydroxyl groups ca n apparently be conjugated
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and eliminated as glucuronide s
oxidi zed to 2,5 -HD .
plus 2-h exanol .

i~ethyl

(DiVin cenz o ~~·,

1976) or can be

!!_-butyl ke tone, yielded the same products

Investigato rs in the same laboratory (K rasa vage

~ ~·,

1980) calculated that the toxicity of administered hexane or its
neurotoxic metabolites was directly related to the integral of 2,5-HD
blood levels over time.
A rigid requirement for "hexaca rbo n" neurotoxicity is the capacity
of a molecule to form a y -di ketone.

O'Donoghue and Krasa vage {19 79)

fou nd 1 g/kg/d ay of 2,5-heptanedione to cause neuropathy identical to
2,5 - HD afte r 13 weeks.

The same dos e of 2,6-he ptanedione did not cau se

Katz~ ~·

neurotoxicity.

{1979) found ethyl !!_-butyl ketone to be

non-neurotoxic after 24 weeks of exposure to 700 ppm.

Serum

concent rations of 2,5-heptanedione were very low compared to those
associated with comparable exposures to MnBK , suggesting that !!_-heptane
and ethyl !!_-butyl ketone do not co nstitute appreciable neurotoxic
hazards.

Hexane mixtu res which are virtually free of !!_-he xane and,

hence, unable to form y -di ketones, failed to cause neuropathy
characte ri stic of 2,5-HD

( Egan~~·,

1980) .

It was primarily studies of hexacarbon neurotoxicity which led
Spence r

~ ~·

( 1978) to the hypothesis that a defect in energy

metabolism in nerve fibers might be the cause of central-peripheral
distal axonopathies.

Subsequently

Sabri~~·

{1979a) reported

decrements in activity of PFK with 2,5-HD but not with non-neuroto xic
2,4-hexanedione.
inhibited GAPDH

Similarly 2,5-HD, and to a greater extent MnBK,
(Sabri~~·,

1979b).

by the addition of dithiothreitol.

Enzyme inhibition was prevented

These investigators inferred that

interaction of hexacarbon metabolites with thiol groups of these enzymes
was the major biochemical lesion leading to neuropathy.
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Graham (1980) pr oposed that 2,5- HD may react with lys ine-ami no
gro ups to fo1111 initial Schiff base monomers or dimers, which after
isomerizati on and subsequent oxidation, could fonn extended conjugated
struct ures.

Ob served spectrophot ometr i c maxima seen when 2, 5- HD but not

when acet on e was added t o GAPDH or other pr oteins are of an app r opriate
wavelength for structures containing three conjugated double bonds
involving oxygen or nitrogen .

Dimer fo1111ation could ac co unt for bond

stability and cross-lin king capacity •11hich may be th e reason fo r
neu r ofilament agg regati on.

More recent ly DeCaprio and Weber (1981)

reported the pr obab l e presence of a cross-linked oxidized pyrrol e
polymer fo1111ed by reaction of

c-lysine gr oup s 1vit h 2,5-HD.

Tri-o -Tolyl Phosphate (TOTP)
Also called tri-o-cresol phosphate, TOTP has been responsible for
thousands of cases of human pe ri pheral neur opathy.

The mo st serious

epi demic in the United States was the resul t of TOTP contam inat ion i n
Jamica ginger , an alcohol ic beve rage widely consumed during the
pro hibi tion (Ludwig, 1977).

TOTP poisoning did not stop with the

recognition of the causative agent.
since then.

Numer ous inc idents have occu rred

Sm it h and Spalding (1959 ) reported over 2,000 cases in

Mo rocco which were attributed to cooking oil contaminated 1vith a mixture
of tritolyl phosphates.

App reciable amounts of ortho-tolyl isomers were

pr esent in the mixtu re .

Even as late as 1978, over 20 people in Sri

Lanka were affected, this time because of TOTP contamination in gingili
oil (Senanayake and Jeyaratnam, 1981).
Cli nical reports were characteristic of distal neuropathy .

A high-

s tepp ing gait due to foot drop, claw hands, wri st drop, and absence of
ankl e reflexes were typical symptoms (Senanayake and Jeyaratnam , 1981) .
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Patients oft en reported heaviness and soreness , pa rt icula rly of calf
muscl es as symptoms which set in after an asymptomatic period of 1-2
weeks .

General feelings of heaviness in the legs, pain and paresthesias

1vere typical; and, as symptoms progressed, muscles atrophied.

Recovery

was sl ow and often incomplete (Ludwig , 1977) .
Tri-~-tolyl

phosphate is not toxic in its native form but is

readily oxidized by 1iver microsomal fractions to a di
~- (

-hydroxy)tolyl phos phate.

-~-tolyl

The latter intermediate can cyclize

s po ntaneousl y , or by the cata ly tic action of plasma albumins, to yield
the neur otoxic pr oduct , 2-phenoxy -4H-1,3,2- ben zodi oxaphosphorin -2- oxide
(Eto

~ ~·,

1967 ) .

Tri-~- tolyl

phosphate is a well-studied model for organophos phate -

delayed neurotoxicity, and is often used as a "positive control" for
comparison of clin i cal or histological findings (Abou-Donia and Graham,
1978).

Technical tritolyl phosphate products are often mixtu res of

isomers , some of which undoubtedly have neurotoxic potential .
~ ~··

Johannsen

(1977) characterized the neurotoxic effects of triaryl - ,

trial ky l-, and aryl -alkyl phosphates in rats and hens.

They found o-

alkylphenyl groups in all neurotoxic compou nds, with decreased neurotoxicity as either the

~- al k yl

group is increased in size or as

addit i onal substitution occu r s on the

~-aklyl - substituted

ring(s) .

Histopathological signs included axonal swelling, followed by vacuolation, clumping and fragmentation of axons, with eventual demyelination
in sciatic nerve and spinal co rd sections .
Delayed Distal Neuropathy Due to Leptophos
and Related Organophosphates
The capacity of leptophos to produce delayed neurotoxicity simi la r
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t o that of TOTP was widely recognized when nume rous water buffalo in the
Nile delta we re paralyzed by the insecticide in 1971 (Abou -Do nia and
Preissig , 19 76) .

Since then several other organophosphates have been

found to cause delayed neuropathy, an d efforts have been made to
characte rize structural features which lead to delayed neuropathic
effects.

Abou -Donia (1979) compa red the delayed neurotoxic effects of

leptophos and four other compou nds diffe ring only in the type of
group or in the substituents on the

~-phenyl

group .

~-alkyl

Neurotoxicity

varied 80- fold over the series, with cyanofenphos and Q-ethyl Q4-n itrophenyl phe nylphosphonothioate, both of which have electronwithd rawing groups in

the~

position of the

~-aryl

groups, being the

most neurotoxic.
Histological effects of organophosphate neurotoxicity common to the
five compounds reported above by Ab ou-Donia {1979) were:

(1) axonal and

mye lin degeneration of distal branchings of the sciatic nerve followed
by (2) degeneration of anteri or columns of the tho racic and lumbar
spinal cord .

One of the earlier of many studies of organophosphate-

delayed neurotoxicity by Abou -Donia and associates (Abou-Donia and
Preissig, 1976) gives what appears to be the most detailed report of
their histological findings.

Hens intoxicated with leptophos

~~e re

sacrificed for chemical and histological analyses after clinical signs
of intoxication (weight loss , progressing ataxia) were observed.

Light

microscopy of sciatic nerve sections of hens which displayed ataxia
revealed

s1~ollen,

often fragmented axons and degenerated myelin.

The

follo wi ng areas of the spinal cord were observed to show ma rked degeneration of axons and myeli n:

( 1) the anterior pathway of the l umb ar

spinal cord; (2) anterior desc endi ng tracts of the thoracic cord
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(degenerati on l ess ad vanced t han in other a rea s) ; (3) l atera l and
ascending posterior tracts of the cervical cord; and (4) lateral
ascending tracts of the medulla.

El-Sebae

~ ~·

(1980) reported

si milar findings in spinal cord and found degeneration of
spino-cerebellar fibers to continue into the cerebell um.

Lesions were

observed predominantly in the distal portions of the larger fibers .
Swollen axons, myelin ovoids marking the place of degenerated axons, and
phagocytosis of degenerated cell contents were reminiscent of st udies by
Spencer an d Schaumburg (1974b ) of histological effects of acrylamide.
Abou -Donia (1979) reported that five analogues of lept ophos caused
delayed distal neuropathy.

Reichert and Abou-Donia (1980 ) i nvestigated

the effects of the same five leptophos analogues and of TOTP on fast
axoplasmic transpo rt.

They found 40-50 percent inhibition of transport

rate of inco rporated 3~-proline in the optic nerve after treatment with
any of the six neurotoxic compounds .

Parathion, wh i ch does not cause

distal neurotoxicity, did not alte r transport rate.
Studies by

Lowndes~~·

(1974) gave strong evidence that

organophosphates damage axons directly, rather than indirectly by
initial action on the cel l body .

A single injection of 25 mg/kg DFP, a

delayed neurotoxic chemical, was injected into the femoral artery at a
locus from which the dose would be distr i buted primarily to the region
below the knee of the injected leg.

Posttetanic potentiation of motor

nerve stimulation of the soleus musc le was most evidently reduced
compared to the contralateral leg two days after injection.
measurable decrement was still observed after 56 days.

A

Because the

distal part of the injected leg was the only majo r body area to receive
DFP before blood returned to the heart fo r general systemic
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di stribution, t he unilate ral effect was co nsidered to reflect dir ect
local effect, probably on the terminal portions of the mot or axons.
Johnson (1975a) described the presence of an esterase enzyme,
"neurotoxic esterase".

It has no known phys i o l ogi cal function but is

spec i fically inhibi t ed by delayed neurotoxic compounds .

An assay of

this esterase, which is somewhat predictive of neurotoxic potential
(Jo hnson, 1977 ) , involves measu ring the difference in residua l esterase
activity between brain (o r other nervous tissue) homogenates incubated
either with paraoxon which do es not cause delayed ne ur ot ox i c ity, or with
paraoxon plus mipafox , which does cause delayed neurotoxicity.
Neurotoxic esterase is found primarily in microsomal fractions of
t he cell (R ichardson and Johnson, 1976) .

Two majo r groups of chemi cals

can inhibit neurotoxic esterase (Johnson, 1975a).

The first group

includes neurotoxic phosphates, phosphoramidates and phosphonates, which
inhibit neurotoxic esterase and are subject to an "agin g" pr ocess
whereby fission of a labile leaving group on the inhibiting molecule
creates a stable, charged and irreversibly bound residue in the active
site .

Other chemicals, such as sulfonates, phosphi nates, and

carbamates, li ke wise bind covalently to neuroto xic esterase, but are
unable to undergo fission, are not irreversibly bound, and may even
serve a protective function by occupying the active site when
administered before challenge by delayed neurotoxic compounds (Johnson,
1974) .

De l ayed neuroto xicity caused by organophosphates may result from

structural changes result in g from a charged species occupying the active
site of neurotoxic esterase (Johnson , 1975a).
Johnson (1975b) has compared st ructure/activity relationships
associ a ted with distal neu r otoxicity .

The effects that va rying
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s ub stituents may ha ve upon presenc e or de gree of ataxia are gi ven fo r
phosphorofluor ida t es, phosphonofl uori dates, phosphates, phos phorothioates, phos phonates, phosphinates, cyclic saligenin esters, and
substituted triaryl phosphates .

Trends in neurotoxic potential, as

individual substituents are systematically varied, are discussed under
generic groupings .
Appreciable human hazard due to organophosphate delayed distal
neurotoxicity can normally be prevented by testing new compounds in
sensitive model s, such as chickens.

Frequent ly, classes of chemicals

known to have many neurotoxic members can be avoided entirely for use as
pesticides, but that is not always necessary .

Hollingshaus

~~·

(1979) found that substitution of an Q-ethyl group for Q-methyl in
leptophos created a compound essentially devoid of delayed neurotoxicity .

Insecticidal potency was unaffected .

Tox i city testing of

chemicals related to known delayed neurotoxic compounds should proceed
with consideration of differential metabolism among species.

Possible

environmental alterations of chemicals which could create neur otoxic
chemicals should also be considered.

One example is the photodegrada -

tion product of leptophos, desbromoleptophos, which has substantially
more delayed neurotoxicity than the parent compound (Hollingshaus
~·,

~

19 79; Abou - Donia, 1979 ) .

Methyl Mercu r ic Chloride
Neurotoxicity due organornercury compounds is fundamentally different from the centr al-peri phe ral distal axonopa thi es associ a ted with
acrylamide, hexacarbons, and certain organophosphates .

Although elemen -

tal mercury and its inorg anic salts are toxic to nervous tissue , the
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organi c f orms are of pa rt icu lar int e r est becau se of th e ir high a f fini ty
f or brain and estab l ished neurotoxi c ity (C hang, 1980) .

The works cited

here deal with Me Hg salts unless otherwise stated.
The tragic

i~inamata

epidemic of i1eHg neurotox i city three deca des

ago offered scientists a close look at several facets of resultant human
path ology.

Ta keuchi ( 1977 ) descri bes gradations of bra i n pathology from

moderate depopulation of sensitive regions of corte x t o a spongy state
r esul t ing from a complete loss of neurons.

All cases autopsied foll ow-

i ng the Minamata incident showed some degeneration of the ca l carine
cortex, the visual center in the occipital region of the brain.
Typically the most serious involvement was in the depth of the calcarine
fissure.

Clinical signs associated with calcarine degeneration ranged

f r om abnormal ocular moveme nts to total blindness.
also underwent characteristic alterations .

Cerebellar cortex

Granule cells 1vere the most

sensitive cells and died in large numbers before Purkinje cells were
visibly affected.
cumbed.

The latter were more resistant, but eventually suc-

Proliferation of glial cells and phagocytic activity occu rre d

in acute and subacute cases.

Peripheral nerves underwent demyelination

and showed numerous abnormal growths of regenerating axons.

Individuals

exposed prenatally or as small children developed the most severe and
most generalized pathological lesions, with involvement of large parts
of the brain .
Ultrastructural studies by

Jacobs~

i.l_. (1977) revealed that MeHg

caused severe destruction of rough endoplasmic reticulum and marked
vacuolization, most evident in dorsal root and cranial nerve ganglion
cells.

Preferential damage to such cells was speculated to be due to

passage of r1eHg through fenestrations in endothelial cells.

These
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authors obs erved that the more sensit i ve cells of the cent ral ne rv ous
system were small and not ric h in ribosomes. These included the stell ate, bas ket, and granule cells of the cerebellum and granule cells and
sma l l neurons of the visual cortex .

Preferential damage to these ce lls

was speculated to be also due to ri bosomal damage , as ribosomes have
considerable proportions of sulfhydryl groups to which me rcurials could
bind .
Somjen ~ ~· (1973) in j ected rats daily subcutaneously with 203Hg labeled MeHg hydroxide and found high est level s in spinal ganglia, folloVIed by cereb ral co rtex and cerebellum.

Yoshino ~~·

(1966a) fou nd

the calca rine cortex of dogs to accumulate 203Hg-labeled MeHg slightly
but significantly more than other cortical areas .

Thus there is a cor-

relation between the amount of r1eHg incorporated into cells and the
degree of pathology.

The same investigators also analyzed cell frac-

tions of rat brain for bound label and found most MeHg incorporation to
be protein bound, with very little binding in nucleic acid or lipid
fractions.
Some of the biochem ical effects observed in MeHg toxicity follow
logically from the preceding pathological findings.

Protein synthesis

rates in rats administered [u-14f]-va l ine were reduced 20-30 percent in
different brain re gions (Omata et

~·,

1980), as mi ght be expected in

cases of severe depletion of cellular rough endoplasmic reticulum .
Yoshino~~ ·

(19 66b) fou nd inhibition of brain uptake of

[u -1 4f] -l eucine in MeHg-treated rats.

These investigato rs assayed the

activities of three sulfhydryl-containing enzymes as animals progressed
from the asymptomatic latent period to a stage wherein rats showe d
neu rological symptoms such as ataxic gait or abnormal postures .

Of the
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three enzymes , aldolase and Mg++-activated ATPa se were not affected by
doses ad ministered, but succinic dehydrogenase •.vas inhibited in r ats
displaying abnormal behavior .

Paterson et al . (1971) found accumulation

of glyceraldehyde - 3-phos phate, 3-phosphoglycerate, and 2-phosphoglycerate
in cerebri of rats killed one hour after ip injections of 5 mg/kg MeHg.
Inhibition of one or more enzymes of glycolysis was inferred,
Methyl mercuric chloride exhibits several effects on neurotransmit ter function.

Kob ayashi

(1980) found decreases in striatal and

~ ~·

co rtica l acetylcholine in mice chronically intoxicated with MeHg and
whi ch had a staggering gait.

Turnover of acetylcholine appeared to be

reduced, but experimental procedures may have been confounded by inhibi tion of the high affinity choline uptake system.

High affinity uptake of

choline by mouse neuroblastoma cells has been decreased by 1 M MeHg
(Prasad~~·,

1979) .

!~ethyl

mercury was found to bind to muscarinic

receptors in rat brain , although to a much lesser extent than HgCl2 (Von
Burg~~ · ,

1980) .

11ethyl mercury also causes an apparent inhibition of

uptake of DA, NE , and 5- HT in rat striatal, cortical , and hypothalamic
synaptosomes, respectively .

All three amines are spontaneously released

from res pective synaptosomes in the presence of 1 to 10 M t1eHg
(Komulainen and Tuomisto , 1981) .
Catecholamine Synthesis, Turnover Rates,
and Major Metabolites
Dopamine and NE a re de r ived prima ri ly or entirely from Ty r , which
is t r ansported across the blood - brain barrier by facilitated diffusion
(Pardridge and Oldendorf , 1977) .

The first metabolic step toward

formation of catecholamine neurotransmitte rs from Ty r is hydroxylation
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by tyrosine hydroxylase, which is the rate limiting step f or production
of NE or DA .

\vhen hydroxylation is blocked by any of several Tyr

analogues, such as c<-methyl Tyr, the initial rates of disappearance of
NE or DA are indicators of turnover rates of the respective
catecholamines

(Moyer~~·,

1979).

Inhibition of the following step,

cataly zed by l-amina acid decarboxylase, produces an initial bu ildup of
DO PA in catecholaminergic neurons or 5-hydroxytryptophan in neurons
whic h produce 5-HT.

Carlsson and Lindqvist {1978 ) inhibited the

decar boxylase with 3-hydroxyben zyl-hydrazi ne HC1 and used the i nit i a1
accumu 1at ion of l-DOPA and 5-hydroxytryptophan to estimate of the
synth etic rates of catecholamines and 5-HT, respec tively .

Since 1-DOPA

is a common precursor toNE and DA, decarboxylase inhibition is of no
value in estimating al te rations in specific neurotransmitter synthesis
rates, except in brain areas where only NE or DA is produced.
Dopam ine

S- hydroxylase converts DA to NE in norepinephrine neurons,

but inhibition of this enzyme to measure a buildup of DA in NE neurons is
futile unless a MAO inhibitor is li kewise added.

Mo re frequently,

in vestigators prevent either the rate-li miting step in the catabolism of
the neurotransmitters, or block the efflux of metabolites.

As an

example, Meek and Neff (1973) observed a linear increase in MOPEG-504
after blocking metabolite efflux with probenecid.
of

r~OPEG-504

pargyline.
inhibition .

An expon ential decline

was observed when they administered the

i~AO

inhibitor,

Likewise DA metabolites disappear exponentially after MAO
Pargyline administration to rats caused exponential decline

in the chief DA metabolite, DOPAC.

Similarly simultaneous administration

of pargyline and the COMT inhibitor, tropolone, caused exponential
decline of HVA , another significant DA metabolite (Westerink and Ko rf,
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1976) .

Estimates of the turnover rates of ,'10PEG -S 04 ba sed on initial

decline of MOPEG - S04 after pargyline 1vere not the same as c>stimates based
upon increase after probenecid treatment.

A disadvantage of probenecid

is that levels near the lethal dose are required to achieve nearly
complete blockage of 110PEG-S04 efflux (Meek and Neff, 1973).

Parglyine

efficiently blocks MAO activity, and the inc rease in NE or DA levels can
be used as an indicator of turnover of the respective catecholamines.
Nevertheless, adding drugs to a system when interactions with test
chemicals are possible is undesirable.
Neff~.!)_.

(1971) described a mean s to measure turnover of brain

catecholamines without interference with metabolism or tra ns port of
these transmitters by drugs.

They injected 0. 8

activity 3.t!_-Tyr into the tail veins of rats.
intervals after a minimufil of 90 minutes time.

~Ci/kg

of high specific-

Animals were killed at
The delay ensured that

blood Tyr levels were sufficiently reduced so that the afilount of
additional 3.t!- Tyr entering DA or NE neurons waul d be small compared to
the amount already present.

Neff~.!)_.

(1971) r eported plasma Tyr

specific activities to be only about 25 percent of tele-diencephalon DA
levels two l10urs after 3.t!_-Tyr injection.

Plasma Tyr radioactivity

continued to drop dramatically for another hour before leveling off.
The rate constant of formation of the monoamine NE or DA, is thus
represented by the equation:
dM ; k

df

m

(A-M)

where M; specific activity of the monoamine
and A

speci fie activity of the precursor amino acid, Tyr.

Determining the above rate constants requires efficient separation
of NE, DA, and Tyr, and accurate measurment of NE and DA, especially
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when the diffe rence in specific activities of NE or DA over tile time
interval is not large compared to t he error inherent in the measu rements .

Moreover, steady state 1eve 1s of neurotransmitters, their

precursors and their metabolites yield additional information when
evaluated in consideration of neu r otransmitte r rates.

Thus in a study

by Meek and Neff (1973) of effects of cold exposure on the NE system, NE
levels remained unchanged while elevated MOPEG-S04 levels suggested that
turnover rates had increased.

Similarly, foot shock stress to rats

elevated NE turnover without affecting steady state levels of NE
(Thierry~~ ·

1968) .

Often chemical administration or stress applica-

tion overcomes or alters the feedback controls which tend to keep neurotransmitter levels somewhat constant.

Furthermore, brain neurotransmit-

ter levels, as well as turnover rates, are often observed to change in
response to the environment .

Thus \vhole brain levels of DA and DA turn-

over undergo diurnal variations in the rat, although whole brain NE
levels and turnover apparently do not (Lemmer and Berger, 1978).
A few examples show the va riety of compounds which have been found
to alter brain levels of neurotransmitters.

Magos and Ja r vis (1970)

found that acute exposure to high concentrations of carbon disulfide,
which causes delayed distal neuropathy symptoms similar to those of
acrylamide and 2,5-HD (Sabri and Spencer, 1980), reduces NE levels and
increases DA levels and turnover rate.

Sharma (1973) found reduced

levels of NE, DA, and 5-HT in mallard ducks chronically exposed to 30
ppm dieldrin.

Holt and Hawkins (1978) found rat hippocampal NE levels

red uced after acute or chronic administration of the organophosphate
pesticide, disulfoton.

Th is reduction lasted at least 48 hours after

the last injection of disulfoton.

Similarly, parathion decreased NE and
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DA levels in ce re bral cortex , but varia bly altered turnover rates in
various brain parts (Fiscus and Va n Meter, 1977) .

It is not surp r ising

that powerful cholinesterease inhibitors affect non-cholinergic as well
as chol inergic neurotransmitte r systems, since the var i ous nerve cell
types are frequently obse r ved to be intimately asso ci ated with each
other.
Brain levels of neu r otransmitte r metabolites can indicate
alterations in neurotransmitter tur nover rates, with or without the
administration of compounds which block acid metabolite efflux across
cell memb ran es , as previ ously discussed .

When the rate co ns ta nts of

neu r otransmitte r s are already known, metabolite levels indicate if
efflux rates from the neuron are no rmal.

Mo noam i ne oxidase ox i dat ivel y

deami nates both NE and DA to their res pective aldehydes.

The 3, 4-

dihyd ro xyphenyl - aceta l-dehyde derived from DA is quick ly oxidi ze d by an
aldehyde dihydrogenase to DOPAC.

Methy l at i on by COMT to form HVA occurs

to va ria bl e extents depending on the br ain r egi on studied (Weste r ink and
Ko rf, 1977) as well as on the species or strain of animal.

These

authors found DOPAC t o be the predomi nant metabo l it e of DA in t he rat.
Norepinephrine is also deamina ted by MAO, but the product is
appa rent ly quantita ti vel y reduced to DOPEG by an aldehyde redu ctase
(Schanberg et

~·

1968) .

3,4-Dihydroxyphenylet hyle negl ycol is part ially

methy lated by COMT to MOPEG,
before excretion .

Bo th products under go sulfate conjugat io n

3,4 -Dihydroxyphenylethyleneglycol sulfate and

MOPEG- S04 are ab out equal in abundance in brain (Karasawa
Meek and Neff, 1973).

n

~·,

1978;

Practical methods for analysis of MOPEG and its

sulfate have bee n available longer than for DOPEG, and MOPEG-S04 leve l
alterations have been ch aracte rized as a useful index of NE tu r nove r
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(Kohno

~~·,

1981) , hence th e re la ti ve abun dance of re po rt s co nce r ning

MO PEG and it s sulfate i n NE metabolism st udies .
Brain AT Pases and t heir Importance
in Catecholamine Transport
Brown and Sh arma (1976) observed that the neu r otoxic organophosphate, TOTP , was more potent than the powerful cholinesterase inhibitor,
mevi nphos, as an inhibitor of chicken spinal cord synaptosomal Na+, K+ ATPase and of ouabain - insensit i ve Mg++-ctependent ATPase .

They

speculated that the comparatively greate r persistence of TOTP in the
central nervous system might account in part both for the greater ATPase
in hibition and neurot ox i c potential displayed by TOTP and a few other
organophos phates.

B rac ken~~ ·

(1981) found that K+ -de pendent

phosphatase activ ity of rat ce rebra l cortex synaptosomal membranes was
not sig nificantly affected by the neurotoxic compounds, DFP or
acrylamide, suggesting that there is probably not a generalized
reduction of ATPase activity associated with neurotoxic compounds .

In

the same study, MeHg and in organic mercu ry were found to strongly
inhibi t K+ -dep endent phosphatase activity .
Yos himura (1973) reported that NE , DA, and 5- HT stimulated
hypothalamic Na+, K+ - ATPases.

Si nce then, many othe rs have investigated

the relationships between membran e transport of biogenic am i nes and
ATPase activities.

Prakash et al . (1973) found a positive co rrelati on

between inhibition of Na+, K+-ATPase by divalent metal i ons and
inhibition of NE and choline upt ake in rat brain synaptosomes.
Co nversely , Godfraind

~~·

(1974) found maximal stimulation of Na+,

EGT A is pr ese nt i n rat brai n homogenates .

Si nce EGTA is an effective

chelator fo r ca ++, and since catecholamines could not further increase
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ATPase activity, these authors speculated that neu rot ransmitte rs capable
of stimulating ATPase activity do so by the mediati on of ca++ sequestration.

Other evidence that NE uptake through the presynaptic membrane is

not a primary action of Na+, K+-ATPase was obtained by Logan and
O'Donovan ( 1980), who found that the order of potency of certain antidepressants i n blocking NE uptake into synaptosomes was di fferent from
the order of potency of the drugs to inhibit Na+, K+ -ATPase activity.
It appears that neurotransmitte r transport against concentration
gradie nts involves carrier proteins and some means of linking the
di rection of carrier-mediated flow with the function of an ATPase .

The

independent actions of the carrier function and ATPase function are more
clear cut in the case of chromaffin granules (Scherman and Henry, 1980 ).
They found reserpine, chlorpromazine, and related drugs to be capable of
80 to 97% inhibition of NE uptake without any effect on the

i~g++

dependent ATPase associated with storage granules or vesicles.

These

authors observed that the pH inside the vesicles 1vas about 1.1 units
lower than the medium, suggesting that the ATPase functions by acidifying the interior of the vesicles to create an "ion-trapping" effect for
sequestering biogenic amines.
feature of storage vesicles.

Ion trapping is possibly a general
Angelides (1980) incorporated a solubil-

ized catecholamine transporter from rat heart synaptic vesicles into
liposomes made from soybean phospholipids an d created viable reconstituted "synaptic vesicles."

When such vesicles were subjected to an

artificial pH gradient, NE and epinephrine were sequestered by the
vesicles.

Reserpine is an extremely effective competitive inhibitor of

catecholamine uptake:

a 10 micromolar reserpine addition reduced NE up-

take to the same very low levels as 1 iposomes 1vithout addition of
carrier protein.
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There is stil 1 much to be learned about memb rane trans po rt and the
associated ATPases .

At least two electrophoretically-distingu ishable

Na+, K+- ATPases are found in brain, and t hey can be differentiated by
t heir degree of inhibition by strophant hidi n (Sv1eadner, 1979 ) .

It

appears that one is predominantl y neuronal and the other form non -neural
in origin.

Some studies have attempted to isolate neural function of

ATPases by assaying "catecholamine sensitive" ATPase activity, i.e.,
i ncremental increases in ATPase activity elicited by NE or DA (Desaiah
and Ho, 1979).

The majority of studies impl ic ating centra l ATP ases

involve in vitro systems and t herefore bypass t he blood - bra in barrier .
An assessment of the true physiological si gni ficance of tox i c potential
is often better achieved in the whole animal.

Subsequent in vitro wo r k

would logically follow in the event that in vivo studies indicate alterations in body function .

Thus specific inhibition of Na+ , K+ - ATPase in

t he neu ra l synapse would be expected to decrease uptake of catechola mi nes
and increase turnover rate, wi t h a reduction of intracellular metabolite
formation and an increase in extracellular metabolite formation .
Bloc kage of or competit i ve interaction with catecholamine transport pro teins would have a similar effect.

Dy sfunction of th e acid metabolite

transport system would be ma nifest in accumulation of metabolites such as
DOPAC or MOPEG-S04.
Motor Disability in Rats Treated with
D1 stal Neuropathoge nic Agents
Farr (1981) assessed motor dysfunction caused by acrylamide, 2,5 - HD,
TOTP, leptophos, and MeHg on rotarod pe rfonnance in rats.
performed as described in Kaplan and

l~ urphy

( 19 72) .

Tests we re

Animals to be tested

were placed on a 3-inch diameter dowel rotating at 20 rpm.

A gridwor k
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capable of producing mild electrical shocks was placed below the dowel ,
and rats soon learned to walk the dowel in order to avoid the shocks .
Tests were performed at least every third day during the dosing period .
Inabil ity to walk the dowel for one minute in at least one of three
trials was conside red as a failure for evaluation purposes .
Farr (1981) found or al dose levels sufficient to elicit rot arod
failu re within a fe1·1 days for all compounds tested .

Daily acrylamide

doses of 50 mg/kg/d ay caused 100 percent failures after 6 days while 15
mg/kg or less caused no decrements in motor ability after 7 days .

One

hundred percent failu r es occu rred in rats administered 300 mg/kg/day
2,5-HD after 5 days.

A more gradual effect was observed in rats given

330 mg/kg TOTP every third day .

These animals failed 80 percent of the

time after 7 days and 100 percent after 16 days .

Rats fed 90 mg/kg

leptophos every third day showed 50 percent failure three days after the
third and final feeding.

Leptophos doses of 30 mg/kg every third day

elicited no consistent motor disabi lity.
3 day intervals caused 100% failure.
after 3 feedings.

Four doses of 10 rng/kg MeHg at

Half that dose caused 60% fai l ure
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MATERIALS AND METHODS
Experi menta 1 Design
Tests were devised to determine whether selected compounds which
cause delayed distal neuropathy impede membrane transport of catecholamine neurotransmitters an d their chief metabolites .

Neurotransmitter

and metabolite levels were assayed fluorometrically to examine doserelated alterations.

Sacrifice of animals at each of two time intervals

fo llovting administration of 3H-Tyr permitted estimation of rate constants of formation of NE and DA, respectively.
Animals
Male Sprague-Dawley derived rats (Simonson Laboratories, Gilroy,
Califo rnia) weighing 200 g were used throughout the experiments.

All

rats were acclimatized to the animal facility surroun dings for at least
six days before testing.

They were fed a commercial la bo ratory chow and

given free access to feed and wat er during experiments .
exposed to 12 hours of ligh t per day.

Animals were

Because rat brain DA levels and

rate constants undergo significant diurnal va riation (Lemmer and Berger,
1978), animals were consistent ly sacrificed at a fixed time of day,
namely during the sixth and seventh hours of the light cycle.
Chemicals and Chemical Assay Equipment
Five neurotoxic chemicals were used.

Acrylamide, 2,5-HD, and TOTP,

practical, were purchased from Eastman Kodak Co ., Rochester, New York.
Methyl mercuric chloride, 95+%, was supplied by Alfa Division, Danvers,
Maine, and leptophos, 98%, by Chern Service, West Chester, Pennsylvania.
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The fol l owi ng s t andards were purchased fr om Sigma Chemi cal Company (St.
Louis, Missouri):
MO PEG- S04

\~as

NE HCl , DA HCl, Tyr, and DOPAC.

The calcium sal t of

purchased from Tri dom Chemica 1 Inc . (Hauppauge, New Yor k) .

Tyrosine, l-[ring-2,6-3H], 38 Ci / nmol, 1 mCi / ml, was pu r chased from New
England Nuclear (Bo s to n, Massachusetts).

Vehicles for administration of

toxins included propylene glycol, U. S. P. (Fisher Scientific Company,
Fair Lawn, New Jersey) , co rn oil (Mazola•) , 95% ethanol, and water.
Atropine sulfate (Sigma Chemical Company) was administered ip to rats in
leptophos st udies.
sample assays

~~ere

All ge l s, resins, buffe r salts, and reagents used in
of a quality suitable for fluorescence studies.

Fluorometric assays were pe rformed on an

Aminco - Bov~an

spectrophotofluorometer (Silve r Spring, Maryla nd) .

A Packa rd Tri - Carb®

2660 Liquid Scintillation Sytem was used for all scintillation
counting.
Dosing
Dose levels were chosen such that only the highest dose levels of
each chemical v10uld cause marked moto r dysfunct ion during the treatment
period.

Comparat i vely short dosing periods were favored because tail -

vein injections of 3~-Tyr could be much more successfully performed in
comparatively small animals with mo re visible veins.
percent of the highest administered dose were given as
controls.

Doses of 30 and 10
1~ell

as vehicle

Details of dosing regimes are summarized in Table 1.

Note

that high doses shown in the table are equivalent to the minimal doses
1~h ich

elicit cons istent moto r disability in studies reported by Farr

(1981) , e xcept that in the present study the hig hest leptophos le vel was
omitted due to very high mortal ity in those animals.
oral intuba tio n using a 16-gauge feeding needle.

All dos ing was by

TABLE
DOSING SCHEDULE FOR FIVE NEUROTOXIC COMPOUNDS
·-~--~~
· -· --~~·~~ --------~ - --

Test Chemical

Dose per
feeding

Vehicle
(volume/kg)

High
Medium
Low

Acryl ami de

2,5-hexanedione

50 mg/kg
15 mg/kg
5 mg/kg

300 mg/kg
100 mg/kg
30 mg/kg

Water
(14.6 ml/kg)

Propylene
glyco l
(10 ml/kg)

Dosing interval
(days)
Total doses
Interval, last
dose to sac rifice
(day s )

5

7

Leptophosa
15 mg/kg
5 mg/kg

Methyl mercury
10 mg/kg
3 mg/kg
1 mg/kg

Tri -.2_-t oly l
Phosphat e
300 mg/kg
100 mg/kg
30 mg/kg

Propylene
glycol
(10 ml/kg)

Ethanol: corn
10: 90
(10 ml/kg)

3

3

3

5

5

6

2

2

Corn oil
(10 ml/kg)

aAnimals rece1v1ng leptophos and their contro l s received 50 mg/kg ip atrop ine sulfate approximat ely
30 minutes before dosing.

w
_.,.

35
3H -tyrosine Administration
Efficient tail -vein injection required warm ing the animal br iefly
1~ith

a heat lamp to cause distension of the veins (A rmin et

~·,

1960 ) .

Rats were injected with a 27-gauge need l e in a lateral vein , usually in
the distal portion of the tail, with a 0. 5 ml aqueous injection volume
containing 62~ Ci of 3!:!.- Ty r.

To determine optimal times between

injection and sacrifice, a group of 12 rats was injected vlith 3!:!_-Tyr and
th ree l'lere sacrificed at each of four hourly intervals.

Table 2 shows

the total activity in fractions containing NE and DA respectively.

Note

that the amount of labelled NE and DA apparently peaks befo re or during
the second hour after 3~-Tyr injection, and that both NE and DA specific
activities decrease after two hours.

Neff

n

~·

(1971) recommended a

minimum of 90 minutes between preinjection of labelled precursor amino
ac ids and sacrifice of the first group of animals due to large
va riability in samplings before 1. 5 hours elapsed time.

The procedure

for fractionation of amines is given later.
Tissue Co llection
Rats were sacrificed by decapitation at predetermined interva ls
following 3~- Tyr injection.

Anima ls awaiting sacrifice were housed at

some distance from the sacrifice room so that levels and turnover
rates of neurotransmitte rs would not be alte red due to excitability
associated with the smell of blood.

Brains we re quickly excised, frozen

on dry ice, and subsequently stored at -90°C until assay.
killed in groups of about 20 in a space of about 1.5 hours .

Animal s were
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TABLE 2
DISINTEGRATIONS PER MINUTE PER NANOMOLE + STANDARD ERROR
IN NOREPINEPHRINE AND DOPAMINE FRACTIONS
AFTER INJECTION WITH 3H -TYROSINE

Hours after injection
4

3

Norepinephrine

209 + 2sa

200 + 44

149 + 51

160 + 71

Dopamine

292 + 25

245

140

126 + 13

aResults are means

+

+
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+

22

standard error for three rats .

Extraction, Fractionation of Extracts,
and Fluorometr1c Assays
Assay of MOPEG-S04 was pe rformed only in acrylamide tests, for
which NE levels were significantly depressed in high dose animals .
Frozen brains were groun d in liquid nitrogen, then shaken in five parts
0.2 N H2S04 .

Assay followed the method of Kohno

summarized here .

~ ~·

{1979), briefly

After centrifugation of the H2S04 extract, supernatant

was neutralized with Ba{OH)2 and centrifuged.

Supernatants were applied

to DEAE-Sephadex A-25 columns, washed with water and 0.06 N HCl, and
eluted with 0. 4 N perchloric acid .

Eluates were developed by heating in

the presence of additional perchlo ric acid and cysteine, followed by
addition of ethylenediamine and reheati ng .
nm excitation, 465 emission.

Fluorescence was read at 325
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3,4-Dihydroxyphenylacetic acid, NE, DA, and Tyr were assayed in
brains of rats 1vhich were preinjected with 3.!!_- Tyr.

Frozen brains 1vere

placed in 0. 4 i1 perchloric acid (PCA) containing, as an antioxidant,
0. 1% NazSz05, and homogenized in a tissue gr inder .

Samples were

centrifuged at 15,000 g, and the supernatants divided for (1) DOPAC and
(2) NE, OA, and Tyr .

3,4- Dihydroxyphenylacetic acid VIas isolated and

assayed fluorometrically by the method of Westerink and Korf (1977) .
3,4- 0ihydroxyphenylacetic acid fractions were neutralized to pH 2. 5

~

0. 5 with concentrated KOH - formate solution, centrifuged, and aliquots of
supernatant added to Sephadex G- 10 columns.

Columns were washed with

0.01 M formic acid and eluted with 0. 005 M phosphate buffer, pH 8.5 .
Fluorescence was de veloped by heating in an acidic solution containing
ethylenediamine, followed by reading at 410 nm/540 nm excitation/
emission .
No repinephrine , DA and Tyr were isolated on Oowex-50 X 4 columns by
a combination of methods of Neff et al. (1971) and

Marin i ~~·

(1979) .

Oowex columns we re conditioned with 2M NaOH, 2M HCl, 4 M NaCl, and
finally with sodium phosphate buffer, pH 6.5, before each use .

Aliquots

of 0. 4 M PCA supernatants we re neutralized . with 5 M KOH to pH 2. 0 - 2. 5.
After centrifugation to remove KCl04 precipitate, 4 ml aliquots we re
applied to Oowex columns (height 3. 5 em, i.d . 4. 9 nm) and effluents were
collected .

Collection continued as 4. 0 ml 0. 1 M sodium acetate buffer,

pH 4. 5, and 2. 0 ml 0. 1 M sodium acetate buffe r, pH 6. 0, were added.
This collection contai ned Ty r , which was ref ri gera t ed for subsequent
purification .

Oowex columns were washed with an additional 8 ml sodium

acetate buffer, pH 6. 0, followed by 5 ml 0.4 M HC l containing 0.1 %
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Na2S205 .

An additional 13 ml of the same HCl solution eluted NE .

Dopamine was t he n eluted with 5 ml 4. 0 M HCl contai nin g 0.1 % Na2S205 .

A

1 ml portio n of tris (hydroxy methyl) aminomethane (t ris buf fer) was
added to each NE and DA f racti on .
2. 0 M NaO H with mixing .

Dopami ne sampl es then rec ei ved 5.0 ml

Samples were normally refri gerated ove rnight

(t hese catecholamines are stable fo r at least a day in these acidic
solu tion s containing Na2S205) .

Tyrosine was t itrated with tris buffer

and NaOH to pH 9 and passed th r ough an alum i num column, wit h collection
of th e enti re elua tes.
to Dowex columns.

These were acidified to pH 1. 5 and applied agai n

Columns were washed with water, D.5 M HCl, and 2.0 ml

0. 1 M trisodium phosphate solut i on.

Final elution fo l lowed wi th an

additional 6.5 ml trisodi um phosphate solution.
Ty r osine was derivitized by the addition of ethanolic
naphthol rea gent and sodium nitrite in 2.67 M HN03 .

1-n it roso-2-

After heating for

colo r developme nt, excess 1-ni t r oso - 2-n ap hthol was ext racted int o
1,2- dichloroethane, and Tyr was assayed fluorometrically at settings
46D/570 nm

(Smith~~.,

1975).

Subsequent processing of NE and DA samples followed the method of
Karasawa et al. ( 19 75) .

Samples were titrated t o pH 8. 0 _:: 0.5 with NaOH

and applied to alum i na columns .

After washing with about 20 ml water,

respective catecholamines were eluted with 3. 0 ml 0.2 M HCl.

Norepin -

ephrine solutions were adjusted to pH 6. 5 and oxidized with !2-Na! sol ution for 20 minutes .
solution.

Oxidation was stopped with basic sodium sulfite

Tubes we re acidified with acetic acid and assayed fluo romet-

rically 1-2 hours late r at 380/480 nm.

Dopamine was oxidized with

potassium ferricyamide, followed by add iti on of alkal ine sulf ite
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solu tion.

Six minutes late r acetic acid was added and samples were

heated to develop fluorophore and assayed at 330/370 nm.
Radiometric Assays
All sc int il lation co unting was performed by adding 2. 0 ml aqueous
solution plus 4. 5 ml of a cocktail (tol uene:
containing 7 g/1 of Preblend 2a70).

Triton X-1 00 (2:1),

The fluor is a pr oduct of Research

Products International Co rp., Elk Grove Vil lage, Illinois.

Al um ina

col umn eluates i n 0.2 M HCl we re mixed directl y with cocktail for DA and
NE samples.

Tyrosi ne samples in 0.1 M phosphate buffer were diluted with

th ree volumes of water before addition to cocktail to give uniform
results.

Samples were warmed for 2- 5 minutes in a 40°C water bath,

vigorously sha ken, and returned to the bath for 20- 30 min utes.

Vials

were gently removed from the bath and cooled in ice water to minimize
phase separation .

Vials were then placed in the scintillation counter

and read in sample channels r at io mode after four hours dar k and
tempe rat ure adaptation .

Data were automaticall y printed in DPM based on

internal quench correction curves .
Calculations and Statistics
Brain levels of chemicals in nmol/g were estimated on the basis of
external standards, which were nonnally added shortly before
fluorescence development.

Samples from rats treated with a given test

compound were processed in three batches except for leptophos, which was
processed in two batches, and recoveries of i nterna 1 standards were
calculated for each batch by comparison with external standards.
Appa rent l evels based upon external standards were then multiplied by
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the mean recovery factors to obtain nmollg values .

Brain homogenate is

assumed to be 70% soluble in PCA, hence when 5 ml PCA are used per gram
brain, the solutes from
extract .

gram brain ar e dissolved in 5. 7 ml PCA

This estimate completes the input data required for the

following equation:
(nmollsample)[recovery co r rect i on (no dimen sions)] X
( samples l g brain) ; nmollg brain
Simila r ly, for estimations of quantit i es of amines per scintillation
vial fo r use in specific activity computations, the equation is:
(nmollsample)(sampleslvial) ; nmollvia l .
Specific activit i es of NE, DA , and Tyr we re calcu l ated as

OPt~lnmol.

Rate constants of fonn at i on of NE or DA we re est imated by the equation
of Neff et al. (1971).
K ; [(Y2 - Y1)1(t2 - t1) J I [(x1 + x2 - Y1 - Y2) I 2]
Where:
K ; synthesis rate co nsta nt of fonnation of NE or DA
Y1 • Y2 ; NE or DA spec i fic act i vity at t ime
a nd t ime 2 afte r injection
of

3~-Ty r ,

respectively

x1, x2 ; Tyr specifi c act i vity at t ime 1 and
t ime 2 after i njection
of 3~- Ty r, respect i vely
t1

2. 0 hour s

t2

3. 5 hours
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The estimate of K fo r given treatment employed mean value s for
specific activities of Tyr and at NE or DA at the respective time
intervals aft er injection.

The standard deviation for a given treatment

group was estimated by systemat i cally re peatin g the calculation of K on
pairs of rats, one in each pre-injection time gr oup , and taking the
standard devia tion of the estimates of K.

The order of entries in the

compared sets of rats was changed seven times, and K values of paired
rat s and r especti ve standard deviations were calculated as before.
Finally, the median va lue of the standard deviation estimates was taken
as the standard deviation of K.
It was assumed that the true differences between the synthes is rate
constants of the vehic le control groups were small compared to the
standard error of the estimate of any set of about seven pairs of rats,
therefore estimates of K for NE and for DA rates were derived from the
pooled specific activity data for all control rats as well as for control
and treatment groups associated with respective neurotoxic chemicals .
Finally the following test statistic for testing the equality of two
means (Ostle and

t~ensing,

1975) 1vas employed to compare the means various

treatment gr oups wi th associated or pooled controls .
Test statistic assumptions :
i.
ii .

Populations to be compared are norma l and i ndependent
Population variance s are eq ual
then
112
t

(Xl - X2) I [S2(lln 1

+

l ln2) J

where

s2

[(nl - l)s2l + (n2 - 1) s22] I (nl + n2 - 2)
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One way analyses of variance for treatment - associated differences
in levels of Tyr, NE, DA , and DOPAC was performed by a Statistical
Package for the Social Sciences {SPSS) batch program, in which Tukey HSD
tests were used to compa re means whenever F probabilities were less than
0.05.

The computing system, ,'1initab II

(Ryan ~

il·,

1976) 1vas used for

all othe r data manipula tion.
To prevent bia s in sample processing, brain homogenates 1vere assayed
in random order.

After levels of Tyr, NE, DA, and DOPAC and their

respective specific activities were calculated, the data were sorted
acco rding to the original serial numbers of the animals, and weights of
animals at the beginning and at the end of tests were recorded.

For each

neurotoxic chemical st ud ied these data were grouped in arrays, which
could then be manipulated in uniform manner for statistics.
The following editing techniques were performed.

In some cases,

recoveries were poor and variable, or portions of samples were knovm to
have been lost.

For these samples, specific activities could be

calculated, but samples could not be used to estimate brain levels of the
respective compounds.
into this category.

Only in the case of Tyr did whole batch es fall
To flag invalid entries i n order to prevent them

from inclusion in brain level calculations, such entries were assigned
zero or negative values.

Some DA entries

~<ere

purged when both DA levels

were calculated to be exceptionally low or high and correspond ing derived
specific activities were exceptionally high or low respectively, casting
doubt on the accuracy of that DA level estimate.

3,4-Dihydroxyphenyl-

acetic acid and DA fluorometric readings occasionally gave readings
several times higher than other samples run in the same batch.

As this

was discovered, subsequent tests used two replicates of DA and DOPAC were
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run together and averaged .
range were ignored.

Read i ngs clearly outside the physiologica l
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RESULTS
Acryl ami de
Acrylamide significantly reduced weight gain in high dose rats
1vhich received a cumulative dose of 250/mg/kg acrylamide (Table 3).
Tremors were noted in 31% of high-dose animals but were not observed in
other groups.

One rat was euthanized after receiving a cumulative dose

of 200 mg/kg .

It was 1veak, showed tremors and labored breathing and

suffe red weight loss of 55 g in four days .

Rats in lower treatment

groups were without apparent cl inical symptoms.
Rate constants of NE and DA synthesis 1ve re unaffected by acryl ami de
treatment (Table 4).

Norepineph rine levels were significantly reduced

in rats receiving 250 mg/kg acrylamide (Table 5).

There were no

significant changes in levels of DA, Tyr, or DOPAC .

3-Methoxy-4-hydroxy-

phenylethyleneglycol sulfate levels did not show statistically
significant differences, but appeared to be reduced in the 250 mg/kg
group .
2,5- Hexanedione
There \vas a trend toward elevated synthesis rate constants for both
NE and DA, with the low-dose group being significantly increased in the
case of DA synthesis rate when compared with 2,5-HD controls (Table 6).
However, 2,5-HD control values for both NE and DA were low compared to
pooled synthesis rate constants estimated for control animals associated
with all five compounds of this study (KNE = 0.22
0.03) .

~

0.03, KoA

0.42

No 2,5-HD treatment groups were significantly different from the
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TABLE 3
BODY WEIGHT GAIN IN RATS GIVEN ORAL DOSES
OF VARIOUS NEUROTOXIC COMPOUNDS
i4elght (g)
Before
Treatments
+ Standard
Error

We1ght (g)
before
Treatments
+ Standard
Error

Amount
Admi nistered
rag/kg/feeding

Cumulative
Dose
mg/kg

Rats
pe r
Group

0
5
15
50

0
25
75
250

15
14
14
13

193 . 7 +
192 . 9 +
193.6 +
195.4 +

2,5-Hexanedioneb

0
30
100
300

0
210
7oof
2100

15
15
14
14

202.0 + 3.1
204.7 + 4.3
203.9 + 2. 8
202 . 9 + 4.2

244.7 + 4.8
243.0 + 4.2
242.5 + 4.0
222 . 9 + 3.9h

Tri-o-toly l
phosphatee

0
30
100
300

of
180
600
1800

14
15
15
14

203 . 5 + 3. 5
210 . 1 + 3. 8
200.5 + 3.7
206.4 + 3.1

292.6 + 4. 0
30 1. 9 + 5.6
288 . 4 + 5.9
299.4 + 5. 3

Methyl
me rcuric
chlorided

0
1
3
10

0
5
15
30

15
15
13
14

202.2 + 4.1
209.2 + 3.3
201.5 + 4. 0
205.3 + 4. 1

296.7 + 4.7
303 . 5 + 4.2
287 . 2 + 6.4
263 . 8 + 7.4h

Leptop has e

0
5
15

0
25
759

14
13
9

206.7 + 6.3
216 . 0 + 3.8
223.0 + 5.6

285.0 + 5. 7
294.6 + 7.5
270 . 7 + 7. 3h

Compound
Administe red
Acrylamidea

aAcrylam1de adm1 n1 stered dally for flVe days.

2.6
2.9
3. 8
4.5

236.1 +
233 . 9 +
233. 0 +
212 . 9 +

3.9
3. 6
2. 7
3. 9h

Rats k1lled on day 6.

b2,5-hexanedione administered daily for seven days.

Rats kill ed on day 8.

CTri-o-tolyl phosphate administered every third day for six doses.
killed one day after last dose.

Rats

dMethyl mercuric chloride administered every third day for five doses .
killed two days after last dose.

Rats

eLeptophos administered after pre-treatment with 50 mg/kg atropine sulfate.
Rats dosed every third day for 5 doses. Rats kil led 2 days after last dose.
fone rat died.
gThree rats died
hsignificant difference in weight gain compared to controls, p < 0.05.
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TABLE 4
SYNTHESIS RATE CONSTANTS OF RAT BRAIN NOREPINEPHRINE AND
DOPAr~IN E

AFTER ORAL ADMINISTRATION
OF ACRY LAMIDEb

Cumul ati ve dose
(mg/kg)

Ka (h r-1 )
NE

0

0.27 + 0. 05

0. 38 + 0.07

25

0. 25 + 0. 04

0.2 7

75

0.3 3 + 0. 04

0.38 + 0. 06

250

0. 31 t 0. 06

0. 36

+

+

0. 12

0. 09

aNorepinephrine synthesis rate constant + SE.
bpooled synthesis rate constants for 35 pairs of rats constituting all
cont rol animals used in the present studies are as follows:
KN E• pooled = 0. 22 t 0.03, KDA · pooled
0. 42 + 0.03.
CDopam ine formation rate constant t SE.
pooled co ntrols .

2,5-Hexanedione did not significantly affect levels of

NE, DA , Tyr or DOPAC in any level of acry lamide administration (Tab l e 7) .
Cumulative administration of 21 00 mg/kg 2,5- HD caused significant
weight loss ( Table 3) .

No other group lost weight, nor were signs of

ataxia observed.
Tri-o-tolyl Phosphate
Synthesis rate constants for NE and DA showed no significan t
diffe ren ces (Table 8) , nor were trends evident in response to the
organophosp hate.

levels of Tyr were significantly elevated in rats fed

the highest dose of TOTP, 1800 mg/kg ( Table 9) .

Dopamine, NE and DOPAC
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TABLE 5
RAT BRAIN LEVELS OF ENDOGENOUS CHENICALS
AFTER FIVE CONSECUTIVE DAYS ORAL
DOSING WITH ACRYLAMIDE
Endogenous
Compound
Norepinephrine

Cumul ative
Dose (mg/kg)
0
25
75
250

Animals per
Treatment
15
14
14
12

Dopamine

0
25
75
250

15
14
13
11

Tyrosine

0
25
75
250

5
4
4
3

DOPAca

0
25
75
250

15
14
14
12

t~OPEG - S04 b

Mean + SE
(nmol/g brain)
2. 88 + 0. 08
2. 87 + 0. 07
2.85 + 0.06
2.50 + 0.07C
5. 19
4.74
5.12
5.29
89 .0
78 . 6
91.6
89 . 0
2. 12
1. 99
2.24
2.22

+
+
+
+

0.27
0.23
0. 16
0. 16

+
+
+
+

4.7
3.7
3. 4
2.4

+
+
+
+

0.09
0. 07
0.08
0. 06

0
10
0. 44+0 . 05
25
0. 38 + 0. 03
9
0.40 + 0.02
75
9
250
9
0.34 + 0.01
a3,4-dihydro xyp henylacetic acid .
b3-met hoxy-4-hydroxyp henylethylene glycol sulfate .
CSignif i cantly different from control values,
p < o. 05.
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TABL E 6
SYNTHESIS RATE CONSTANTS OF NOREPINEPHRINE AND
DOPAMINE AFTER ORAL ADMINISTRATION
OF 2,5-HEXANEDIONEb
Ka
NE
hr-1

K
DA
hr-1)

0

0.1 6 + 0.06

0.32 + 0. 07

210

0.20 + 0.04

o.51

700

0. 33 + 0. 05

0.50 + 0. 05

0.32

0.48

Cumulative dose
(mg/kg)

2100

aNorepinephrine synthesis rate constant

+

+

0.04

+

+

o.o4d

0.04

SE.

bpoo led synthesis rate constants for 35 pairs of rats constituting all
control animals used in the present studies are as follows: KNE•
pooled = 0.22 ~ 0.03, KDA• pooled = 0.42 ~ 0.03.
CDopamine synthesis rate constant + SE.
dsignificantly different from 2,5-hexanedione control values , p<0 .05.
levels did not differ from control values in TOTP studies.

Uniquely

among compou nds tested in this series, TOTP did not alter weight gain at
any dose level (Tabl e 3).

No clinical symptoms were observed in TOTP

animals.
Leptophos
A cumulative leptophos dose of 75 mg/kg sharply reduced weight gain
(Table 3).

Three rats died during treatment of the group administered

15 mg/kg/feeding.

Five out of nine rats fed 30 mg/kg leptophos died
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TABLE 7
RAT BRA! N LEVELS OF ENDOGENOUS CHEtHCALS AFTER
SEVEN CONSECUTIVE DAYS ORAL DOSING
\liTH 2,5-HEXANEDIONE

Endogenous
Compound

Cumulative
Dose (mg/kg)

Anima 1s per
Treatment

Norepinephrine

0
210
700
2100
0
210
700
2100
700
210
700
2100
0
210
700
2100

15
14
14b
14
14
15
14
14
10
10
10
9
15
13
14
14

Dopamine

Tyrosine

DOPAca

f1ean + SE
(nmol/g-brain)
2. 60
2.61
2.64
2. 47
4. 84
5.08
4.92
4.91
143 . 7
142.3
152 . 9
146.3
0.9 7
0. 98
0. 91
1.01

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

0. 06
0.06
0. 06
0. 09
0.16
0.14
0. 12
0.12
3. 6
4.0
3.1
5.0
0. 04
0. 05
0. 05
0. 05

a3,4- dihydroxyphenylacetic acid .
bo ne rat receiving 700 mg/kg cumulative dose died during treatment.
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TABLE 8
SYNTHESIS RATE CONSTANTS OF NOREPINEPHRINE AND
DOPAMINE AFTER ORAL ADMINISTRATION
OF TRI-o - TOL YL PHOSPHA TEb

Ka
NE
(hr-1)

KC
DA
(hr-1)

0

0.19 + 0.06

0.38 + 0. 06

180

0.21 + 0. 04

0.52 + 0.07

700

0. 10 + 0.06

0.29 + 0.09

2100

0.33 + 0.06

0.37 + 0.07

Cumulative dose
(mg/kg)

aNorepinephrine synthesis rate

constant~

SE.

bpooled synthesis rate constants for 35 pairs of rats constituting all
control animals used in the present studies are as follows: KNE•
pooled = 0.22 ~ 0. 03, KoA, pooled = 0.42 ~ 0.03.
coopamine synthesis rate

constant~

SE.

after a single feeding, and dosages at that level had to be
discontinued .

These deaths occurred despite pre-treatment of rats with

50 mg/kg atropine sulfa e ip.
become highly excitable.

Atropine was sufficient to cause rats to

A survivor of a single 45 mg/kg feeding had

tremors, which co ntinued fo r at least 48 hours after dosing .

At that

time the animal was unusually reactive to stimuli such as being gently
blown upon from behind .
A significantly high NE rate constant was noted in the 75 mg/kg
gr oup (Table 10), however, such significance may simply reflect the low
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TABLE 9
RAT BRAIN LEVELS OF ENDOGENOUS CHD~ICA LS AFT ER SIX
ORAL DOSES AT THREE DA Y INTERV ALS OF
TRI-o-TOLYL-PHOSPHATE
End ogenous
Compound
No repinephr ine

Do pamine

Tyrosine

DOPACa

Cu mulative
Dose (mg/kg)
0
180
600
1800
0
180
600
1800
0
180
600
1800
0
180
600
1800

Animals per
treatment
14b
15
15
14
14
14
15
14
13
14
15
14
14
15
13
14

a3,4-dihydroxyphenylacetic acid.
bone cont rol animal died during treatment period.
c Sign i fi cantl y different from contra l values, p<O. 05.

~1ean + SE
(n mol / g brain)

2.45 + 0.07
2. 61 + 0. 07
2.48 + 0.06
2.56 + 0.04
4.49 + 0.13
4.77+0.09
4. 82 + 0.13
4.68 + 0.11
127.6 + 3.5
126.5 + 3.2
132.6 + 4.6
143 .2 + 3.2C
0.95 + 0.05
0.96 + 0. 04
0.93 + 0. 05
0.89 + 0.04
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TABLE 10
SYNTHESIS RATE CONSTANTS OF NOREPINEPHRINE AND DOPAMINE
AFTER ORAL ADMINISTRATION OF LEPTOPHOSC
Cumulative dose
(mg/kg)

Ka
NE
(h r-1 )

Kd
DA
(h r - 1)

0

0. 18

+

0. 03

0.39

+

0. 04

25

0.19

+

0.04

0. 34

+

0.07

75

0. 30

+

0. 04b

0.49

+

0. 07

aNorepinephrine fo rmation rate

constant~

SE.

bsignificantly different from leptophos control group, p<0 . 05 .
CPooled synthesis rate constants for 35 pairs of rats constituting al l
control animals used in the present studies are as follows: KNE•
pooled = 0. 22 ~ 0. 03, KDA· pooled = 0.42 ~ 0.03. Three rats of medium
dose group died du r ing treatment.
dDopamine formation rate constant~ SE.
control value; a KNE estimate of 0.30 is well within the normal range.
Dopamine levels were elevated above cont r ols in rats receiving a
cumulative dose of 75 mg/kg (Table 11).

No other statistically

significant results were observed in levels of endogenous compounds,
however, rat s at the above dosage appeared to have elevated DOPAC
1evel s.
Methyl Mercuric Chloride
A MeHg cumulative dose of 50 mg/kg was sufficient to reduce growth
rate (Table 3).

Rate constant estimates of NE synthesis show no clear

pattern, however, the KNE estimate associated with a cumulative dose of
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TAB LE 11
RAT BRAIN LEVELS OF ENDOGENOUS CHEMICALS AFTER
ORAL ADMINISTRATION OF LEPTOPHOS
Endogenous
Compound

Cumulative
Dose (mg/k g)

Animals per
Treatment

Norepinephrine

0

14

2.60 + 0. 05

25

12

2. 57 + 0.08

75
Dopamine

Tyrosine

9b

2.58+0. 04

0

14

4.93 + 0. 09

25

12

4.95 + 0.20

75

9

5. 61 + 0.19C

0

14

116.3 + 3.3

25

12

109.7 + 3.5
112.9 + 2.2

75
DOPAca

Mean +SE
(nmoT/g brain )

0

14

0.88 + 0.02

25

13

0.90 + 0. 03

75

9

0. 99 + 0.03

a3,4-dihydroxyphenylacetic acid.
bThree rats of medium dose group died during treatment.
Cp ( 0. 05 .
15 mg/kg was elevated and statistically significant when compared to
poo 1ed cant ro 1 va 1ues (Tab 1e 12).

Dopamine rate constant estimates were

significantly lower than MeHg control values at all dose levels.

No

significant differences were observed in NE, DA, or DOPAC levels (Table
13), however, the lowest and highest dosage groups had significantly
lower Tyr levels than controls.
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TABLE 12
SYNTH ESIS RATE CONSTANTS OF NOREPINEPHRINE AND
DOPAMINE AFTER ORAL
r~ETHYL

AD~1INISTRATION

OF

MERCURIC CHLORIDEC

Cumulative dose

K
NE
(hr-1)

(mg/k g)

K
DA
( hr-1)

0.30

+

0.07

0.53

+

0.06

0. 21

+

0. 04

o.26

+

o.o6b,

15

o.39

+

o.o5b

0.3 7

+

o. o5e

50

0. 20

+

0. 08

0.29

+

o. o7e

0

aNorepinephrine formation rate co ns tant

+

SE .

bsignificantly different from pooled means of control groups
associated with five studies of neurotoxic compounds, p<0.05.
CPooled synthesis rate constants for 35 pairs of rats constituting all
control animals used in the present st udi es are as follows: KN E,
pooled = 0. 22 ~ 0.03, KoA, pooled = 0.42 ~ 0.03.
doopamine formation rate constant + SE.
esignificantl y different from met hyl me rcuric chloride control
group, p<O. 05 .
Tyrosine Specific Activities
Spec ific activities of Tyr at the two time intervals after 3~-Tyr
injectio n are summarized in Table 14 for all neurotoxic compounds
studied .

There were no significant differences between control groups

and respective treatment groups two hours after 3~- Tyr injection.
one treatment group (TOTP, cumulative dose 600 mg/kg) varied from
control specific activity at 3.5 hours.

Only
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TABLE 13
RAT BRAIN LEVELS OF ENDOGENOUS BRA I N CHEtHCALS IN RATS
AFTER FI VE ORAL DOSES AT THREE- DAY INTERVALS
OF t1ETHYL MERCU RI C CH LORID E
En dogenous
Compound

Cumulat i ve
Dose (mg/kg)

Anima 1s per
Treatme nt

Norepinephrine

0

15

2.16

5

15

2.1 6 + 0. 03

15

13

2. 15

+

0. 04

50

14

2.24

+

0. 05

0

13

4.83.:: 0. 19

14

4.54

15

13

5.07.:: 0. 18

50

11

4. 81

0

15

109 . 3

+

2.4

5

14

94.7

+

3. 0b

15

13

107.9

+

4. 4

50

13

94 . 8

+

3. 7b

0

15

0.93

+

0. 04

5

15

0.99

+

0. 04

15

13

0.94

+

0. 05

50

14

0.87

+

0. 04

Dopami ne

Tyrosin e

DOPAca

a3,4-dihydroxyphenylacetic acid .
bp<0 . 05 .

Mean + SE
(nmol/g brain)
+

+

+

0. 04

0.2 6

0. 21
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TABLE 14
SPECIFIC ACTIVITY OF TYROSINE IN RATS TREATED WITH FIVE
NEUROTOXIC COMPOUNDS AT nW TH1E
INTERVALS AFTER INJECTION
Compound
administered

Cumulat ive
dose
(mg/kg)

Acryl ami de

Specific activity
3 5 hr. after
3H- Tyrosine
injection (DPM/ nmo l)

6,5

36,5 :: 3.9

25

69 . 1 + 11.1

42 . 1 + 7. 0

75

65 .9 +

7. 4

37.4:: 5, 3

250

77 . 5 +

7.1

41.2::_4.0

0

2, 5-Hexaned i one

0
210
7ooa
2100
oa

Tri -.2_-t o lyl
phosphate

Specific activity
2 hr. after
3H- Tyrosine
injection (DPM/ nmol )
63.8::

77 . 9::_

3. 6

49.8 + 4.1

75.4::

3.7

44. 7 + 1. 2

81. 8 ::

4. 4

52 .1:: 3.3

81. 1 ::

3.1

52.2::_2.4

62.8::

3. 9

35,3::_1.7

180

60. 7 ::

2.3

600

65 . 7 ::

4.6

31.0:: 1.8
40 , 0 :!:_ 1,2C

1800

75 . 2::

4.1

37 . 0 + 2. 5

Methyl mercuric

0

60. 2 ::

2.5

41. 0 :: 4. 4

chlo r ide

5

52.5::

2. 7

33. 8 + 1. 3

15

68. 7 ::

5.8

37 . 9:: 1.1

50

63 . 9 ::

2. 7

43. 5 :: 1. 8

Leptophos

0

56. 7 ::

3. 9

33.8:: 1. 5

25
75b

56.3::

5.0

33.1:: 2. 7

59 . 3 +

7. 5

33.2:: 3. 2

aone rat died .
bTh ree rats died.
CSignificant, p<0.05.
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DISCUSSION
Comparison of Experimental Cat echo l amine and
Levels and of Catecholamine Turnover
Rat es with Llte ra ture Values

r~etabo lite

Dopamine and NE levels reported here were in the range reported for
whole brain

{Sm ith~~.,

1975 ,

Marini~~.,

1979 ) .

Fuller and Perry

{1978) report DOP AC levels of about 0.67 mnol /g in Wistar rats , whereas
th e median valu es i n these studies were 0. 95 nmol/g .

W
esteri nk and Ko rf

{1977) reported H'I A levels about 60% as high as DOPAC level s in Wistar
rats , whereas Simonson Sp rag ue - Dawley derived rats used in this
laboratory showed HVA levels scarcely above backg r ound levels .

It is

possible that lower COMT activities i n our animals accounts for low HVA
levels and slightly higher DOPAC levels than reported fo r Wista r rats .
Ra t MOPEG-S04 levels report ed by Kohno et al. {1981) and t1eek and Neff
{1973) 1vere comparable to those reported here in acrylarnide studies.
Reported synthesis rate co nstants for NE in brain stern and
tele -dience phalo n were 0.26 hr-1 and 0.28 hr-1 (N eff~~., 1971) and
0. 34 hr -1 for DA in tele-diencephalon for Sprague-Dawley r ats.

Control

averages in this l abo rat ory were 0.22 hr-1 and 0.42 hr-1 for NE and DA,
respectively, in whole brain .

Norepinephrine rate constant estimations

are observed to have large standard errors relative to the values of the
estimates.

Th is problem arises primarily because estimates are based

almost entirely on the difference between the specific activities of NE
at two points in time, betwe en which only a modest decline in specific
activity occurs .

A small percent error in estimates of specific

activities, therefore, becomes very significant in comparison lvi th
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values of derived rate constants .

Dopam ine specific activi ty drops mo re

dramatically over the same interv al and standard error estimates
relat i ve to the value of the rate constant estimates are smaller than
for NE.

Serotonin synthesis rate constant estimates can be estimated

with greater prec i s io n than either of the catecholamines because of a
rapid decline in specific act ivity during the second hou r after
inj ection

( Neff~~.,

1971).

Two potential problems exist relating to

the contribution of Tyr to the equation of
given on page 41.

Neff~~·

(1971) which is

The first pr obl em, co ntributions to t he brain pool of

3J:!.-Tyr from circulating blood, appears to be quite mi nima l after two
hours or more following iv injection of 3J:!.- Tyr (Neff ~~. , 1971) so
that brain 3J:!.-Tyr levels can be considered to be undergoing
approxi mately first order reduction by this time.

The second pro blem

resides in the possibility that the rate of disappearance of 3J:!.- Tyr in
dopaminergic neur ons might be sufficiently different from that of
noradrenergic neurons to bi as the res pect ive estimates of the synthesis
rate constants in whole brain studies.

The choice of two hours for the

initial post-injection sampling time tends to minimize the effects of
thi s potentia l source of error because specific activity of Tyr is small
at that time (a bout 30 percent in t he present studies) compared to that
of either of the resultant catecholamines .
Acrylamide
The failure of rats administered 50 mgjkgjday acrylamide to
maintain normal weight gain is consistent wi th reports of other
1aboratori es (Til son

~ ~· ,

1979; Schotman

~ ~· ,

1977) .

Tremors as

observed in these tests were reported previously at comparable dose
levels

(Schaumberg~~.,

1974) .
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Dixit et al. {1980) repo rted that steady state le vels of NE, DA and
5-HT were reduc ed in rats intoxicated with cumulative doses of 450 mg/kg
acrylamide .

The present study, employing cumulative doses up to 250

mgjkg , found decrements only in NE levels .
were used by Farr

~~·

When the same dose levels

{1981) prior to 5- HT assay, no dose - related

changes in 5- HT levels were observed .
Bondy~~ ·

{1981) found that acrylamide doses as low as

mgj kgj day for a cumulative dose of 50 mg/kg were sufficient to increase
striatal DA receptor binding .

Increased binding , ta ken together with

decreased response to the DA agonist , apomorphine, suggested to the
investigators an impairment in function of DA neurons i nnervating the
corpus st r iatum .

The present studies found whol e brain DA levels and

synthesis rate con s tants to be unaffected by acrylamide t reatment
despite the fact that co rpus striatum contains a large percentage of
total brain DA (Karasawa

~~··

1975).

The possibility of differential

effects in individual brain areas cannot be discounted .
Rate constants for NE and DA were not affected by levels of
acrylamide tested .

Specific activities of Tyr at the two time interval s

were not altered by dose levels, suggesting that transport of th e
prec urso r ac ross the blood-brain ba r rie r

~~a s

normal.

No significant

al terations were observed in the catecholamine metabolites DOPAC or
MOPEG - S04.

In a previous study,

Aldous ~~··

{1981) noted small but

sig ni ficant increase in DOP AC l eve ls in rats administered acrylamide in
the same dose leve ls as th e prese nt study .

Farr

~~·

{1981) found a

dose -related i nc rease in accumulation of 5-HIAA at cumulative ac rylamide
doses as low as 25 mgjkg with no change in synthesis ra t e constant for
5-HT .

This suggests an impairment of acid metab olite trans po rt to which
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5-HT neurons are at least ten times more se ns itive than catecholamine
neu r ons .
2,5- Hexanedi one
The highest level of 2,5 - HD tested, 21 00 mg/kg cumulative dose,
caused significant decrements in weight gain .
pu blished reports (K rasavage

~~··

1980;

Th is is consistent with

Takeuchi~~ ··

1980).

Access of Tyr to brain tissue and subseq uen t tu r nover of Tyr appear to
be no rmal , based upon s pecific acti viti es of 3_1:!_- Tyr at the
injection intervals .
pa ral lel study , Farr

t'.-10

pos t -

No changes i n NE, DA or DOPAC were observed.
~ ~·

In a

( 1981) observed a dose -re lated increa se in

5-HIAA in response to 2,5- HD administration.

Rate constants of NE and

DA appear to have increased at cum ulati ve doses at or above 700 mg/ kg
and 210 mg/kg , respectively.

Only the OA rate constant for rats dosed

210 mgjkg was signific antly different from control values .

Testi ng

procedures employed in these studies do not distinguish between several
possible causes of increased synthesis rate in the absence of
alterations in steady state levels .

One possibility is increased

stimulation of catecholaminergic neur ons within their neurot ransmitter
replenishing capacity .

Another is impaired uptake of extracellular

catecholamines i nto the cell or of intracellular catecholamines into
synaptic vesic les , either one of which would subject amines to rapid
oxidation by MAO .
Tri- o-tolyl Phos phate
No dose of TOTP administered in thes e studies affected growth rates
of rats.

Levels of catecholam ines and of DOPAC were un affected by doses

of TOTP employed , nor was any apparent trend i n synthesi s rates
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observed.

Al t hou gh there is a statisticall y sign i f i cant var i ati on in

mean spec if ic act ivi ties of 3.t!_-Tyr in rats killed 3.5 hours afte r
injection, no systematic evidence of alterations of norma l Tyr ent ry
into brain or meta bolism therein was obse rved .
TOTP examined 1vere

belo~1

Appa rently levels of

the thresholds .vhich affect the functio ns of

the catecholamin ergi c system .
Leptophos
Hi gh acute toxic i ty l imited t he number of experimental sub j ects
av aila ble in the higher dose gr oups despi te pre- treatmen t of rats with
50 mgj kg atropine sulfate.

The highest t reatment gr oup to receive all

five pl anned doses was ad min istered a cumulative dose of 75 mg/kg .

This

was su fficien t to cause mar ked diminuation of weight gain .
No repineph rine leve ls were normal, but DA levels in rats adminis tered 75
mg / kg were elevated to a modest but statistically s ignificant degree .
Synt hesis rate cons t an t va lue s for DA were unchanged .

A statistically

significant increase in NE ra te constant wa s observed fo r 75 mg / kg rats .
Freed~~·

{1976) fo und that amounts of mi pafox sufficient to cause

at axia l owered DA lev els by 46% .

The alterations reported in this study

are very mino r by comparison, and it is li kel y that they do not
repres ent a physiologically significant response .

A fea t ure of

choli nes t eras e inhibito r toxicity is variable response of catecholamine
levels and turnove r rates in various brain regions {Fiscus and Va n
Meter, 1977).
Me thy l Mercuric Chlo r ide
Spec i fic activities of Tyr in brai n do not vary with dose,
suggesting normal function of the ar omat ic amino acid facilitated
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transport system into the brain .

Organic and inorganic mercury com-

pounds have been rep orted to dam age the blood - brain barrier and to cause
extravasation of blood ma rkers into t he central nervous system .

Further-

more, i nhibition specific carrier -mediated uptake of amino acids has been
reported after low level HgCl2 administration (St einwall , 1977) .
No al teratio ns were observ ed in levels of NE, DA or DOPAC .
Synthesis rate constant estimates for OA were signi fi cantly incre ased in
all treatment groups, however an atypically high control val ue probabl y
exaggerates true treatment effects on calculated rate constants of
treatment gr oups .

Note espe cially t hat th e gr oup recei vi ng the highest

cumulative dose had a rate const ant very near to the mean of OA control
rate constants of 0. 42 .

Evide nce of alterations in monoam i ne f unct i on

due to MeHg sho uld not be surp risin g i n view of membrane dysfu nction s
reported fo r biogenic amines (Kom ulainen an d Tuomisto , 1981) .

Reduced

tu r nove r of DA could also result fran reduced sti mulatio n by cholinergic
fibers .

An apparent reduction of acety l ocholine turnover has been

reported fo r diffe rent brain areas after MeHg administration (Kobayashi
~~· · 1980) .

Co nclusi ons
Frequently , biochemical or histo log ical lesions resu l ting from
chemical intoxication can be obse rved much earlier in the prog ressi on of
t he disea se than clini cal s ign s are evident.

Examples are early

degeneration of distal nerve f ibers i n the absence of mo tor deficits in
acrylamide toxicity

(T ils on~ ~··

1979 ) and increased OA receptor

bi nding after administ r ation of acrylamide leve ls far below those
s uff icient to elicit clinical sym ptom s (Ag r awal et

~· ·

1981) .

Tests

described in this report included assays of catechola mine levels and
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synthesis rates, as well as studies of possible impaired transport of the
catecholamine precursor and of catecholamine metabolites in response to
several neurotoxic compounds administered at or below the lower threshold
at 'llhich clinical symptoms are observed.

It had been hypothesized for

several reasons that biogenic amine levels would be reduced in rats given
sufficient acrylamide or 2,5- HD to elicit ataxia.

Sabri and Spencer

(1980) found that common biochemical lesions were caused by acrylamide
and 2,5 - HD .

Agrawal !!.

~·

(1981) inferred that acrylamide damages brain

biogenic amine fibers, particularly those of the nigrostriatal
dopaminergic tract .

Except in the case of a modest decrease in NE levels

in rats given 250 mg/kg acrylamide, present results do not support this
hypothesis .

The observation that 2,5-HD apparently increases the

synthesis rate constant of NE and DA without alte rin g steady state levels
of the catecholamines could suggest increased excitation or excitabil ity
of ne rons, or inhibition of catecholamine re - uptake.

The poss ibility

that re-uptake of catecholamine is inhibited seems very unlikely in the
case of acrylamide, as concent rati ons as high as 10-3M failed to inhib it
~vitro
~·,

re- uptake of NE or 5-HT i n rat co rtical synaptosomes (B racken!!.

1981).

Present results do not support the hypothesis that damage to

catecholamine rgic fibers wo uld result in substantial reductions i n steady
state levels of NE orDAin brain.
The organophosphates, TOTP and leptophos, likewise did not alter
catecholam ine functions as measured in the present experiments, except
that the highest dose of leptophos administered elicited an increase in
brain DA steady state concentrations, a change which was opposite in
sign and small in magnitude compared to studies reported by Freed et
(1976 ).

~·

Present results suggest that these two organophosphates do not
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r educe catecholamine levels, as had been expected, nor were
catecho l amine synthesis rate constants affected .

In concl usion,

administration of four chemically distinct agents of delayed distal
neuropathy did not yield marked or consistent responses in the central
catecholaminergic system of the rat.

65

SUMMARY
Ac rylami de, 2,5-HD, TOTP, and leptophos, fou r compounds lihich cause
a cent ral-peri pheral distal axonopathy, and MeHg 1·1ere administered to
rats.

The largest doses applied were sufficient to cause ataxia.

Assays of brain NE and DA levels and levels of majo r metabolites were
perfo rmed .
follo~ling

Synthesis rate constants for NE and DA were calcu lated
injection of radiolabeled common precursor, Tyr.

Cumulative acrylamide doses of 250 mg/kg significantly reduced
brain NE levels.

2,5 -HD significantly increased DA synthesis rate

constants at a cum ulative dose of 210 mg/kg and appeared to increase
both NE and DA synthesis rate constants at higher dosages.

Leptophos

slightly increased brain DA levels in rats administered 75 mg/kg .
Methyl mercu ri c chlo rid e variably affected NE synthesis rate constant
and lowered DA synthesis rate constant at doses of 5 and 50 mg/kg.
Uniform specific activities of brain Tyr following intravenous injection
of the same suggested that no apparent alterations had occurred in
function of the blood-brain barrier .

Rats given the highest doses of

each neurotoxic compound gained less weight than controls, except in the
case of TOTP, which did not affect weight gain at doses up to 1800
mg/kg .

These tests suggest that alteration in central nervous system

catecholami ne function is not a primary effect of these neurotoxic
compounds .
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